BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Palumbo R, Sampaolesi M, De Marchis F, Tonlorenzi R, Colombetti S, Mondino A, Cossu G, Bianchi ME. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J Cell Biol. 2004;164:441-449. [PMID: 14744997 DOI: 10.1083/jcb.200304135] [Cited by in Crossref: 330] [Cited by in F6Publishing: 330] [Article Influence: 18.3] [Reference Citation Analysis]
Number Citing Articles
1 Bianchi ME, Manfredi A. Chromatin and cell death. Biochim Biophys Acta. 2004;1677:181-186. [PMID: 15020058 DOI: 10.1016/j.bbaexp.2003.10.017] [Cited by in Crossref: 89] [Cited by in F6Publishing: 93] [Article Influence: 4.9] [Reference Citation Analysis]
2 Weijer R, Broekgaarden M, Kos M, van Vught R, Rauws EA, Breukink E, van Gulik TM, Storm G, Heger M. Enhancing photodynamic therapy of refractory solid cancers: Combining second-generation photosensitizers with multi-targeted liposomal delivery. Journal of Photochemistry and Photobiology C: Photochemistry Reviews 2015;23:103-31. [DOI: 10.1016/j.jphotochemrev.2015.05.002] [Cited by in Crossref: 74] [Cited by in F6Publishing: 43] [Article Influence: 10.6] [Reference Citation Analysis]
3 Urbich C, Chavakis E, Dimmeler S. Homing and Differentiation of Endothelial Progenitor Cells. In: Marmé D, Fusenig N, editors. Tumor Angiogenesis. Berlin: Springer Berlin Heidelberg; 2008. pp. 309-24. [DOI: 10.1007/978-3-540-33177-3_17] [Cited by in Crossref: 1] [Reference Citation Analysis]
4 Rosenberg HF, Oppenheim JJ. Interview with Dr. Maurizio C. Capogrossi regarding Pivotal Advance: High-mobility group box 1 protein-a cytokine with a role in cardiac repair. Journal of Leukocyte Biology 2007;81:38-40. [DOI: 10.1189/jlb.1306165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Liu Y, Yuan Y, Li Y, Zhang J, Xiao G, Vodovotz Y, Billiar TR, Wilson MA, Fan J. Interacting neuroendocrine and innate and acquired immune pathways regulate neutrophil mobilization from bone marrow following hemorrhagic shock. J Immunol 2009;182:572-80. [PMID: 19109190 DOI: 10.4049/jimmunol.182.1.572] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
6 Yang J, Chen L, Yang J, Ding J, Rong H, Dong W, Li X. High mobility group box-1 induces migration of vascular smooth muscle cells via TLR4-dependent PI3K/Akt pathway activation. Mol Biol Rep. 2012;39:3361-3367. [PMID: 21698364 DOI: 10.1007/s11033-011-1106-6] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 4.3] [Reference Citation Analysis]
7 Broggi A, Granucci F. Microbe- and danger-induced inflammation. Mol Immunol 2015;63:127-33. [PMID: 25037632 DOI: 10.1016/j.molimm.2014.06.037] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
8 Taniguchi N, Caramés B, Ronfani L, Ulmer U, Komiya S, Bianchi ME, Lotz M. Aging-related loss of the chromatin protein HMGB2 in articular cartilage is linked to reduced cellularity and osteoarthritis. Proc Natl Acad Sci U S A 2009;106:1181-6. [PMID: 19139395 DOI: 10.1073/pnas.0806062106] [Cited by in Crossref: 86] [Cited by in F6Publishing: 81] [Article Influence: 6.6] [Reference Citation Analysis]
9 Li J, Gong Q, Zhong S, Wang L, Guo H, Xiang Y, Ichim TE, Wang CY, Chen S, Gong F. Neutralization of the extracellular HMGB1 released by ischaemic damaged renal cells protects against renal ischaemia-reperfusion injury. Nephrol Dial Transplant. 2011;26:469-478. [PMID: 20679140 DOI: 10.1093/ndt/gfq466] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 5.4] [Reference Citation Analysis]
10 Cossu G, Sampaolesi M. New therapies for muscular dystrophy: cautious optimism. Trends in Molecular Medicine 2004;10:516-20. [DOI: 10.1016/j.molmed.2004.08.007] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 2.9] [Reference Citation Analysis]
11 Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, Strassheim D, Sohn JW, Yamada S, Maruyama I, Banerjee A. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol. 2006;290:C917-924. [PMID: 16267105 DOI: 10.1152/ajpcell.00401.2005] [Cited by in Crossref: 644] [Cited by in F6Publishing: 639] [Article Influence: 37.9] [Reference Citation Analysis]
12 Fahmy-Garcia S, van Driel M, Witte-Buoma J, Walles H, van Leeuwen JPTM, van Osch GJVM, Farrell E. NELL-1, HMGB1, and CCN2 Enhance Migration and Vasculogenesis, But Not Osteogenic Differentiation Compared to BMP2. Tissue Eng Part A 2018;24:207-18. [PMID: 28463604 DOI: 10.1089/ten.TEA.2016.0537] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
13 Ge WS, Wu JX, Fan JG, Wang YJ, Chen YW. Inhibition of high-mobility group box 1 expression by siRNA in rat hepatic stellate cells. World J Gastroenterol 2011; 17(36): 4090-4098 [PMID: 22039322 DOI: 10.3748/wjg.v17.i36.4090] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
14 Chan JK, Roth J, Oppenheim JJ, Tracey KJ, Vogl T, Feldmann M, Horwood N, Nanchahal J. Alarmins: awaiting a clinical response. J Clin Invest. 2012;122:2711-2719. [PMID: 22850880 DOI: 10.1172/jci62423] [Cited by in Crossref: 316] [Cited by in F6Publishing: 169] [Article Influence: 31.6] [Reference Citation Analysis]
15 Tagliafico E, Brunelli S, Bergamaschi A, De Angelis L, Scardigli R, Galli D, Battini R, Bianco P, Ferrari S, Cossu G, Ferrari S. TGFβ/BMP activate the smooth muscle/bone differentiation programs in mesoangioblasts. Journal of Cell Science 2004;117:4377-88. [DOI: 10.1242/jcs.01291] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 3.2] [Reference Citation Analysis]
16 Taniguchi N, Yoshida K, Ito T, Tsuda M, Mishima Y, Furumatsu T, Ronfani L, Abeyama K, Kawahara K, Komiya S, Maruyama I, Lotz M, Bianchi ME, Asahara H. Stage-specific secretion of HMGB1 in cartilage regulates endochondral ossification. Mol Cell Biol 2007;27:5650-63. [PMID: 17548469 DOI: 10.1128/MCB.00130-07] [Cited by in Crossref: 67] [Cited by in F6Publishing: 42] [Article Influence: 4.5] [Reference Citation Analysis]
17 Garg AD, Martin S, Golab J, Agostinis P. Danger signalling during cancer cell death: origins, plasticity and regulation. Cell Death Differ 2014;21:26-38. [PMID: 23686135 DOI: 10.1038/cdd.2013.48] [Cited by in Crossref: 132] [Cited by in F6Publishing: 123] [Article Influence: 14.7] [Reference Citation Analysis]
18 Monette MM, Evans DL, Krunkosky T, Camus A, Jaso-Friedmann L. Nonspecific cytotoxic cell antimicrobial protein (NCAMP-1): a novel alarmin ligand identified in zebrafish. PLoS One 2015;10:e0116576. [PMID: 25689842 DOI: 10.1371/journal.pone.0116576] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 de Carvalho GC, Borget M, Bernier S, Garneau D, da Silva Duarte AJ, Dumais N. RAGE and CCR7 mediate the transmigration of Zika-infected monocytes through the blood-brain barrier. Immunobiology 2019;224:792-803. [DOI: 10.1016/j.imbio.2019.08.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
20 Gaskell H, Ge X, Nieto N. High-Mobility Group Box-1 and Liver Disease. Hepatol Commun 2018;2:1005-20. [PMID: 30202816 DOI: 10.1002/hep4.1223] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
21 Colombo E, Giannelli SG, Galli R, Tagliafico E, Foroni C, Tenedini E, Ferrari S, Ferrari S, Corte G, Vescovi A, Cossu G, Broccoli V. Embryonic stem-derived versus somatic neural stem cells: a comparative analysis of their developmental potential and molecular phenotype. Stem Cells 2006;24:825-34. [PMID: 16339994 DOI: 10.1634/stemcells.2005-0313] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
22 Li M, Sun L, Luo Y, Xie C, Pang Y, Li Y. High-mobility group box 1 released from astrocytes promotes the proliferation of cultured neural stem/progenitor cells. International Journal of Molecular Medicine 2014;34:705-14. [DOI: 10.3892/ijmm.2014.1820] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
23 Manfredi AA, Sabbadini MG, Ferri L, Bianchi ME, Rovere-querini P. Mechanisms of systemic vasculitis. Drug Discovery Today: Disease Mechanisms 2004;1:297-302. [DOI: 10.1016/j.ddmec.2004.11.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
24 Cuppari C, Manti S, Chirico V, Caruso R, Salpietro V, Giacchi V, Laganà F, Arrigo T, Salpietro C, Leonardi S. Sputum high mobility group box-1 in asthmatic children: a noninvasive sensitive biomarker reflecting disease status. Ann Allergy Asthma Immunol 2015;115:103-7. [PMID: 26250770 DOI: 10.1016/j.anai.2015.06.008] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
25 Li J, Ke X, Yan F, Lei L, Li H. Necroptosis in the periodontal homeostasis: Signals emanating from dying cells. Oral Dis 2018;24:900-7. [PMID: 28763140 DOI: 10.1111/odi.12722] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
26 Liu H, Yao YM, Yu Y, Dong N, Yin HN, Sheng ZY. Role of Janus kinase/signal transducer and activator of transcription pathway in regulation of expression and inflammation-promoting activity of high mobility group box protein 1 in rat peritoneal macrophages. Shock 2007;27:55-60. [PMID: 17172981 DOI: 10.1097/01.shk.0000233197.40989.31] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
27 Chung HW, Jang S, Kim H, Lim JB. Combined targeting of high-mobility group box-1 and interleukin-8 to control micrometastasis potential in gastric cancer. Int J Cancer. 2015;137:1598-1609. [PMID: 25821182 DOI: 10.1002/ijc.29539] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
28 Seo YS, Kwon JH, Yaqoob U, Yang L, De Assuncao TM, Simonetto DA, Verma VK, Shah VH. HMGB1 recruits hepatic stellate cells and liver endothelial cells to sites of ethanol-induced parenchymal cell injury. Am J Physiol Gastrointest Liver Physiol 2013;305:G838-48. [PMID: 24091596 DOI: 10.1152/ajpgi.00151.2013] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
29 Dumitriu IE, Baruah P, Manfredi AA, Bianchi ME, Rovere-Querini P. HMGB1: guiding immunity from within. Trends Immunol. 2005;26:381-387. [PMID: 15978523 DOI: 10.1016/j.it.2005.04.009] [Cited by in Crossref: 239] [Cited by in F6Publishing: 235] [Article Influence: 14.1] [Reference Citation Analysis]
30 Allmen EU, Koch M, Fritz G, Legler DF. V domain of RAGE interacts with AGEs on prostate carcinoma cells. Prostate 2008;68:748-58. [PMID: 18302220 DOI: 10.1002/pros.20736] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
31 Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 2005;115:572-83. [DOI: 10.1172/jci200524283] [Cited by in Crossref: 498] [Article Influence: 29.3] [Reference Citation Analysis]
32 Sato F, Maruyama S, Hayashi H, Sakamoto I, Yamada S, Uchimura T, Morita Y, Ito Y, Yuzawa Y, Maruyama I, Matsuo S. High mobility group box chromosomal protein 1 in patients with renal diseases. Nephron Clin Pract 2008;108:c194-201. [PMID: 18311084 DOI: 10.1159/000118942] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
33 Ding J, Cui X, Liu Q. Emerging role of HMGB1 in lung diseases: Friend or foe. J Cell Mol Med. 2017;21:1046-1057. [PMID: 28039939 DOI: 10.1111/jcmm.13048] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
34 Loperfido M, Jarmin S, Dastidar S, Di Matteo M, Perini I, Moore M, Nair N, Samara-Kuko E, Athanasopoulos T, Tedesco FS, Dickson G, Sampaolesi M, VandenDriessche T, Chuah MK. piggyBac transposons expressing full-length human dystrophin enable genetic correction of dystrophic mesoangioblasts. Nucleic Acids Res 2016;44:744-60. [PMID: 26682797 DOI: 10.1093/nar/gkv1464] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
35 Soliman NA, Abdel Ghafar MT, El Kolaley RM, Hafez YM, Abo Elgheit RE, Atef MM. Cross talk between Hsp72, HMGB1 and RAGE/ERK1/2 signaling in the pathogenesis of bronchial asthma in obese patients. Mol Biol Rep 2020;47:4109-16. [PMID: 32424522 DOI: 10.1007/s11033-020-05531-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
36 Yang D, Wei F, Tewary P, Howard OM, Oppenheim JJ. Alarmin-induced cell migration. Eur J Immunol 2013;43:1412-8. [PMID: 23619968 DOI: 10.1002/eji.201243138] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
37 Tagami K, Yujiri T, Tanimura A, Mitani N, Nakamura Y, Ariyoshi K, Ando T, Fujii Y, Tanizawa Y. Elevation of serum high-mobility group box 1 protein during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilisation. Br J Haematol 2006;135:567-9. [PMID: 17054673 DOI: 10.1111/j.1365-2141.2006.06335.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
38 Zhao L, Hu Y, Sun J, Sun L. The high mobility group box 1 protein of Sciaenops ocellatus is a secreted cytokine that stimulates macrophage activation. Developmental & Comparative Immunology 2011;35:1052-8. [DOI: 10.1016/j.dci.2011.03.025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
39 Ranzato E, Martinotti S, Pedrazzi M, Patrone M. High mobility group box protein-1 in wound repair. Cells 2012;1:699-710. [PMID: 24710526 DOI: 10.3390/cells1040699] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
40 Eldufani J, Nekoui A, Blaise G. Nonanesthetic Effects of Ketamine: A Review Article. Am J Med 2018;131:1418-24. [PMID: 29753795 DOI: 10.1016/j.amjmed.2018.04.029] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
41 Bertheloot D, Latz E. HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins. Cell Mol Immunol 2017;14:43-64. [PMID: 27569562 DOI: 10.1038/cmi.2016.34] [Cited by in Crossref: 203] [Cited by in F6Publishing: 204] [Article Influence: 33.8] [Reference Citation Analysis]
42 Cui XS, Shen XH, Kim NH. High mobility group box 1 (HMGB1) is implicated in preimplantation embryo development in the mouse. Mol Reprod Dev 2008;75:1290-9. [PMID: 17290427 DOI: 10.1002/mrd.20694] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
43 Marchetti C, Di Carlo A, Facchiano F, Senatore C, De Cristofaro R, Luzi A, Federici M, Romani M, Napolitano M, Capogrossi MC, Germani A. High mobility group box 1 is a novel substrate of dipeptidyl peptidase-IV. Diabetologia 2012;55:236-44. [PMID: 21656024 DOI: 10.1007/s00125-011-2213-6] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
44 Feng XJ, Liu SX, Wu C, Kang PP, Liu QJ, Hao J, Li HB, Li F, Zhang YJ, Fu XH, Zhang SB, Zuo LF. The PTEN/PI3K/Akt signaling pathway mediates HMGB1-induced cell proliferation by regulating the NF-κB/cyclin D1 pathway in mouse mesangial cells. Am J Physiol Cell Physiol 2014;306:C1119-28. [PMID: 24760979 DOI: 10.1152/ajpcell.00385.2013] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
45 Rovere-Querini P, Capobianco A, Scaffidi P, Valentinis B, Catalanotti F, Giazzon M, Dumitriu IE, Müller S, Iannacone M, Traversari C, Bianchi ME, Manfredi AA. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 2004;5:825-30. [PMID: 15272298 DOI: 10.1038/sj.embor.7400205] [Cited by in Crossref: 434] [Cited by in F6Publishing: 422] [Article Influence: 24.1] [Reference Citation Analysis]
46 Pérez LM, de Lucas B, Bernal A, Gálvez BG. Adipokines disrupt cardiac differentiation and cardiomyocyte survival. Int J Obes 2020;44:908-19. [DOI: 10.1038/s41366-019-0455-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
47 Riuzzi F, Sorci G, Donato R. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo. J Biol Chem. 2006;281:8242-8253. [PMID: 16407300 DOI: 10.1074/jbc.m509436200] [Cited by in Crossref: 76] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
48 Cai J, Xia H, Huang Y, Lu Y, Wu Z, Jian J. Molecular cloning and characterization of high mobility group box1 (Ls-HMGB1) from humphead snapper, Lutjanus sanguineus. Fish Shellfish Immunol 2014;40:539-44. [PMID: 25120217 DOI: 10.1016/j.fsi.2014.08.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
49 Yang D, de la Rosa G, Tewary P, Oppenheim JJ. Alarmins link neutrophils and dendritic cells. Trends Immunol. 2009;30:531-537. [PMID: 19699678 DOI: 10.1016/j.it.2009.07.004] [Cited by in Crossref: 161] [Cited by in F6Publishing: 149] [Article Influence: 12.4] [Reference Citation Analysis]
50 Chung HW, Lim JB, Jang S, Lee KJ, Park KH, Song SY. Serum high mobility group box-1 is a powerful diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma. Cancer Sci. 2012;103:1714-1721. [PMID: 22703527 DOI: 10.1111/j.1349-7006.2012.02358.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]
51 Tukhvatulin AI, Logunov DY, Shcherbinin DN, Shmarov MM, Naroditsky BS, Gudkov AV, Gintsburg AL. Toll-like receptors and their adapter molecules. Biochemistry (Mosc) 2010;75:1098-114. [PMID: 21077829 DOI: 10.1134/s0006297910090038] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
52 Romero R, Chaiworapongsa T, Savasan ZA, Hussein Y, Dong Z, Kusanovic JP, Kim CJ, Hassan SS. Clinical chorioamnionitis is characterized by changes in the expression of the alarmin HMGB1 and one of its receptors, sRAGE. J Matern Fetal Neonatal Med 2012;25:558-67. [PMID: 22578261 DOI: 10.3109/14767058.2011.599083] [Cited by in Crossref: 64] [Cited by in F6Publishing: 69] [Article Influence: 6.4] [Reference Citation Analysis]
53 Penzo M, Habiel DM, Ramadass M, Kew RR, Marcu KB. Cell migration to CXCL12 requires simultaneous IKKα and IKKβ-dependent NF-κB signaling. Biochim Biophys Acta 2014;1843:1796-804. [PMID: 24747690 DOI: 10.1016/j.bbamcr.2014.04.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
54 Choi S, Ferrari G, Tedesco FS. Cellular dynamics of myogenic cell migration: molecular mechanisms and implications for skeletal muscle cell therapies. EMBO Mol Med 2020;12:e12357. [PMID: 33210465 DOI: 10.15252/emmm.202012357] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
55 Feng L, Xue D, Chen E, Zhang W, Gao X, Yu J, Feng Y, Pan Z. HMGB1 promotes the secretion of multiple cytokines and potentiates the osteogenic differentiation of mesenchymal stem cells through the Ras/MAPK signaling pathway. Exp Ther Med 2016;12:3941-7. [PMID: 28105126 DOI: 10.3892/etm.2016.3857] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
56 Khambu B, Huda N, Chen X, Antoine DJ, Li Y, Dai G, Köhler UA, Zong WX, Waguri S, Werner S, Oury TD, Dong Z, Yin XM. HMGB1 promotes ductular reaction and tumorigenesis in autophagy-deficient livers. J Clin Invest 2018;128:2419-35. [PMID: 29558368 DOI: 10.1172/JCI91814] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 11.0] [Reference Citation Analysis]
57 Russo AJ. Increased Epidermal Growth Factor Receptor (EGFR) Associated with Hepatocyte Growth Factor (HGF) and Symptom Severity in Children with Autism Spectrum Disorders (ASDs). J Cent Nerv Syst Dis 2014;6:79-83. [PMID: 25249767 DOI: 10.4137/JCNSD.S13767] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
58 Khoo CP, Roubelakis MG, Schrader JB, Tsaknakis G, Konietzny R, Kessler B, Harris AL, Watt SM. miR-193a-3p interaction with HMGB1 downregulates human endothelial cell proliferation and migration. Sci Rep 2017;7:44137. [PMID: 28276476 DOI: 10.1038/srep44137] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
59 Sachdev U, Cui X, Tzeng E. HMGB1 and TLR4 mediate skeletal muscle recovery in a murine model of hindlimb ischemia. J Vasc Surg 2013;58:460-9. [PMID: 23414695 DOI: 10.1016/j.jvs.2012.11.071] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
60 Riuzzi F, Sorci G, Beccafico S, Donato R. S100B engages RAGE or bFGF/FGFR1 in myoblasts depending on its own concentration and myoblast density. Implications for muscle regeneration. PLoS One. 2012;7:e28700. [PMID: 22276098 DOI: 10.1371/journal.pone.0028700] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
61 Zhu S, Li W, Ward MF, Sama AE, Wang H. High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation. Inflamm Allergy Drug Targets 2010;9:60-72. [PMID: 19906009 DOI: 10.2174/187152810791292872] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
62 Yanai H, Ban T, Taniguchi T. High-mobility group box family of proteins: ligand and sensor for innate immunity. Trends Immunol. 2012;33:633-640. [PMID: 23116548 DOI: 10.1016/j.it.2012.10.005] [Cited by in Crossref: 107] [Cited by in F6Publishing: 108] [Article Influence: 10.7] [Reference Citation Analysis]
63 Ojima K, Oe M, Nakajima I, Shibata M, Chikuni K, Muroya S, Nishimura T. Proteomic analysis of secreted proteins from skeletal muscle cells during differentiation. EuPA Open Proteomics 2014;5:1-9. [DOI: 10.1016/j.euprot.2014.08.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
64 Ladrech S, Mathieu M, Puel J, Lenoir M. Supporting cells regulate the remodelling of aminoglycoside-injured organ of Corti, through the release of high mobility group box 1. Eur J Neurosci 2013. [DOI: 10.1111/ejn.12290] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 0.2] [Reference Citation Analysis]
65 Serrano-Del Valle A, Anel A, Naval J, Marzo I. Immunogenic Cell Death and Immunotherapy of Multiple Myeloma. Front Cell Dev Biol 2019;7:50. [PMID: 31041312 DOI: 10.3389/fcell.2019.00050] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 18.0] [Reference Citation Analysis]
66 Palumbo R, Galvez BG, Pusterla T, De Marchis F, Cossu G, Marcu KB, Bianchi ME. Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-kappaB activation. J Cell Biol. 2007;179:33-40. [PMID: 17923528 DOI: 10.1083/jcb.200704015] [Cited by in Crossref: 196] [Cited by in F6Publishing: 194] [Article Influence: 14.0] [Reference Citation Analysis]
67 Zhu N, Yuan W, Zhou Y, Liu J, Bao J, Hao J, Miao W. High mobility group box protein-1 correlates with microinflammatory state and nutritional status in continuous ambulatory peritoneal dialysis patients. J Artif Organs 2011;14:125-32. [PMID: 21442152 DOI: 10.1007/s10047-011-0561-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
68 Yang D, Chen Q, Yang H, Tracey KJ, Bustin M, Oppenheim JJ. High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol. 2007;81:59-66. [PMID: 16966386 DOI: 10.1189/jlb.0306180] [Cited by in Crossref: 272] [Cited by in F6Publishing: 269] [Article Influence: 17.0] [Reference Citation Analysis]
69 Wang LJ, Lu L, Zhang FR, Chen QJ, De Caterina R, Shen WF. Increased serum high-mobility group box-1 and cleaved receptor for advanced glycation endproducts levels and decreased endogenous secretory receptor for advanced glycation endproducts levels in diabetic and non-diabetic patients with heart failure. Eur J Heart Fail 2011;13:440-9. [PMID: 21266376 DOI: 10.1093/eurjhf/hfq231] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 4.5] [Reference Citation Analysis]
70 Zhou X, Hu X, Xie J, Xu C, Xu W, Jiang H. Exogenous high-mobility group box 1 protein injection improves cardiac function after myocardial infarction: involvement of Wnt signaling activation. J Biomed Biotechnol 2012;2012:743879. [PMID: 22675257 DOI: 10.1155/2012/743879] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
71 Bianchi ME, Manfredi AA. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev. 2007;220:35-46. [PMID: 17979838 DOI: 10.1111/j.1600-065X.2007.00574.x] [Cited by in Crossref: 410] [Cited by in F6Publishing: 207] [Article Influence: 29.3] [Reference Citation Analysis]
72 Plotkin LI, Essex AL, Davis HM. RAGE Signaling in Skeletal Biology. Curr Osteoporos Rep 2019;17:16-25. [PMID: 30685821 DOI: 10.1007/s11914-019-00499-w] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
73 Robert SM, Sjodin H, Fink MP, Aneja RK. Preconditioning with high mobility group box 1 (HMGB1) induces lipoteichoic acid (LTA) tolerance. J Immunother 2010;33:663-71. [PMID: 20664360 DOI: 10.1097/CJI.0b013e3181dcd111] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
74 Kang R, Tang D, Schapiro NE, Loux T, Livesey KM, Billiar TR, Wang H, Van Houten B, Lotze MT, Zeh HJ. The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics. Oncogene 2014;33:567-77. [PMID: 23318458 DOI: 10.1038/onc.2012.631] [Cited by in Crossref: 129] [Cited by in F6Publishing: 132] [Article Influence: 14.3] [Reference Citation Analysis]
75 Liu H, Yao YM, Ding LH, Zhang H, Yuan B, Song Q, Ye QN, Huang CF, Sheng ZY. High mobility group box-1 protein acts as a coactivator of nuclear factor of activated T cells-2 in promoting interleukin-2 transcription. Int J Biochem Cell Biol 2009;41:641-8. [PMID: 18707018 DOI: 10.1016/j.biocel.2008.07.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
76 Andersson A, Covacu R, Sunnemark D, Danilov AI, Dal Bianco A, Khademi M, Wallström E, Lobell A, Brundin L, Lassmann H, Harris RA. Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis. J Leukoc Biol 2008;84:1248-55. [PMID: 18644848 DOI: 10.1189/jlb.1207844] [Cited by in Crossref: 140] [Cited by in F6Publishing: 134] [Article Influence: 10.0] [Reference Citation Analysis]
77 Totsingan F, Bell AJ Jr. Interaction of HMG proteins and H1 with hybrid PNA-DNA junctions. Protein Sci 2013;22:1552-62. [PMID: 23963921 DOI: 10.1002/pro.2342] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
78 Manfredi AA, Capobianco A, Esposito A, De Cobelli F, Canu T, Monno A, Raucci A, Sanvito F, Doglioni C, Nawroth PP, Bierhaus A, Bianchi ME, Rovere-Querini P, Del Maschio A. Maturing dendritic cells depend on RAGE for in vivo homing to lymph nodes. J Immunol 2008;180:2270-5. [PMID: 18250435 DOI: 10.4049/jimmunol.180.4.2270] [Cited by in Crossref: 80] [Cited by in F6Publishing: 79] [Article Influence: 5.7] [Reference Citation Analysis]
79 Shim EJ, Chun E, Lee HS, Bang BR, Kim TW, Cho SH, Min KU, Park HW. The role of high-mobility group box-1 (HMGB1) in the pathogenesis of asthma. Clin Exp Allergy 2012;42:958-65. [PMID: 22909167 DOI: 10.1111/j.1365-2222.2012.03998.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 5.9] [Reference Citation Analysis]
80 Ivanov S, Dragoi AM, Wang X, Dallacosta C, Louten J, Musco G, Sitia G, Yap GS, Wan Y, Biron CA, Bianchi ME, Wang H, Chu WM. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 2007;110:1970-81. [PMID: 17548579 DOI: 10.1182/blood-2006-09-044776] [Cited by in Crossref: 322] [Cited by in F6Publishing: 316] [Article Influence: 21.5] [Reference Citation Analysis]
81 Germani A, Limana F, Capogrossi MC. Pivotal advances: high-mobility group box 1 protein--a cytokine with a role in cardiac repair. J Leukoc Biol 2007;81:41-5. [PMID: 16940333 DOI: 10.1189/jlb.0306165] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
82 Hreggvidsdottir HS, Ostberg T, Wähämaa H, Schierbeck H, Aveberger AC, Klevenvall L, Palmblad K, Ottosson L, Andersson U, Harris HE. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J Leukoc Biol 2009;86:655-62. [PMID: 19564572 DOI: 10.1189/jlb.0908548] [Cited by in Crossref: 203] [Cited by in F6Publishing: 207] [Article Influence: 15.6] [Reference Citation Analysis]
83 Otto A, Collins-Hooper H, Patel K. The origin, molecular regulation and therapeutic potential of myogenic stem cell populations. J Anat 2009;215:477-97. [PMID: 19702867 DOI: 10.1111/j.1469-7580.2009.01138.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 4.2] [Reference Citation Analysis]
84 Dormoy-Raclet V, Cammas A, Celona B, Lian XJ, van der Giessen K, Zivojnovic M, Brunelli S, Riuzzi F, Sorci G, Wilhelm BT, Di Marco S, Donato R, Bianchi ME, Gallouzi IE. HuR and miR-1192 regulate myogenesis by modulating the translation of HMGB1 mRNA. Nat Commun 2013;4:2388. [PMID: 24005720 DOI: 10.1038/ncomms3388] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 6.0] [Reference Citation Analysis]
85 Borde C, Barnay-Verdier S, Gaillard C, Hocini H, Maréchal V, Gozlan J. Stepwise release of biologically active HMGB1 during HSV-2 infection. PLoS One 2011;6:e16145. [PMID: 21283827 DOI: 10.1371/journal.pone.0016145] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
86 Wolfson RK, Chiang ET, Garcia JG. HMGB1 induces human lung endothelial cell cytoskeletal rearrangement and barrier disruption. Microvasc Res 2011;81:189-97. [PMID: 21146549 DOI: 10.1016/j.mvr.2010.11.010] [Cited by in Crossref: 139] [Cited by in F6Publishing: 134] [Article Influence: 11.6] [Reference Citation Analysis]
87 Sanaei R, Rezaei N, Aghamohammadi A, Delbandi AA, Teimourian S, Yazdani R, Tavasolian P, Kiaee F, Tajik N. Evaluation of the TLR negative regulatory network in CVID patients. Genes Immun 2019;20:198-206. [PMID: 29618830 DOI: 10.1038/s41435-018-0022-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
88 Pugliese M, Sfacteria A, Oliva G, Falcone A, Gizzarelli M, Passantino A. Clinical Significance of ROMs, OXY, SHp and HMGB-1 in Canine Leishmaniosis. Animals (Basel) 2021;11:754. [PMID: 33803468 DOI: 10.3390/ani11030754] [Reference Citation Analysis]
89 Pandolfi F, Altamura S, Frosali S, Conti P. Key Role of DAMP in Inflammation, Cancer, and Tissue Repair. Clin Ther 2016;38:1017-28. [PMID: 27021609 DOI: 10.1016/j.clinthera.2016.02.028] [Cited by in Crossref: 80] [Cited by in F6Publishing: 86] [Article Influence: 13.3] [Reference Citation Analysis]
90 Tang D, Kang R, Xiao W, Wang H, Calderwood SK, Xiao X. The anti-inflammatory effects of heat shock protein 72 involve inhibition of high-mobility-group box 1 release and proinflammatory function in macrophages. J Immunol 2007;179:1236-44. [PMID: 17617616 DOI: 10.4049/jimmunol.179.2.1236] [Cited by in Crossref: 88] [Cited by in F6Publishing: 92] [Article Influence: 5.9] [Reference Citation Analysis]
91 Sachdev U, Lotze MT. Perpetual change: autophagy, the endothelium, and response to vascular injury. J Leukoc Biol 2017;102:221-35. [PMID: 28626046 DOI: 10.1189/jlb.3RU1116-484RR] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
92 Hamada N, Maeyama T, Kawaguchi T, Yoshimi M, Fukumoto J, Yamada M, Yamada S, Kuwano K, Nakanishi Y. The role of high mobility group box1 in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2008;39:440-447. [PMID: 18441281 DOI: 10.1165/rcmb.2007-0330oc] [Cited by in Crossref: 127] [Cited by in F6Publishing: 71] [Article Influence: 9.1] [Reference Citation Analysis]
93 Chavakis E, Dimmeler S. Homing of Progenitor Cells to Ischemic Tissues. Antioxidants & Redox Signaling 2011;15:967-80. [DOI: 10.1089/ars.2010.3582] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
94 Nierkens S, den Brok MH, Ruers TJ, Adema GJ. Radiofrequency Ablation in Cancer Therapy: Tuning in to in situ Tumor Vaccines. In: Keisari Y, editor. Tumor Ablation. Dordrecht: Springer Netherlands; 2013. pp. 39-59. [DOI: 10.1007/978-94-007-4694-7_3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
95 Yamada S, Maruyama I. HMGB1, a novel inflammatory cytokine. Clin Chim Acta. 2007;375:36-42. [PMID: 16979611 DOI: 10.1016/j.cca.2006.07.019] [Cited by in Crossref: 110] [Cited by in F6Publishing: 108] [Article Influence: 6.9] [Reference Citation Analysis]
96 Zahradka P. Novel role for osteopontin in cardiac fibrosis. Circ Res. 2008;102:270-272. [PMID: 18276921 DOI: 10.1161/CIRCRESAHA.107.170555] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
97 Burns G, Ortega-martinez O, Dupont S, Thorndyke MC, Peck LS, Clark MS. Intrinsic gene expression during regeneration in arm explants of Amphiura filiformis. Journal of Experimental Marine Biology and Ecology 2012;413:106-12. [DOI: 10.1016/j.jembe.2011.12.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
98 Gautam CS, Mahajan SS, Sharma J, Singh H, Singh J. Repurposing Potential of Ketamine: Opportunities and Challenges. Indian J Psychol Med 2020;42:22-9. [PMID: 31997862 DOI: 10.4103/IJPSYM.IJPSYM_228_19] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
99 Straino S, Di Carlo A, Mangoni A, De Mori R, Guerra L, Maurelli R, Panacchia L, Di Giacomo F, Palumbo R, Di Campli C, Uccioli L, Biglioli P, Bianchi ME, Capogrossi MC, Germani A. High-mobility group box 1 protein in human and murine skin: involvement in wound healing. J Invest Dermatol 2008;128:1545-53. [PMID: 18239618 DOI: 10.1038/sj.jid.5701212] [Cited by in Crossref: 113] [Cited by in F6Publishing: 113] [Article Influence: 8.1] [Reference Citation Analysis]
100 Dumitriu IE, Baruah P, Bianchi ME, Manfredi AA, Rovere-Querini P. Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells. Eur J Immunol. 2005;35:2184-2190. [PMID: 15915542 DOI: 10.1002/eji.200526066] [Cited by in Crossref: 144] [Cited by in F6Publishing: 143] [Article Influence: 8.5] [Reference Citation Analysis]
101 Ito T, Maruyama I. Thrombomodulin: protectorate God of the vasculature in thrombosis and inflammation. J Thromb Haemost 2011;9 Suppl 1:168-73. [PMID: 21781252 DOI: 10.1111/j.1538-7836.2011.04319.x] [Cited by in Crossref: 103] [Cited by in F6Publishing: 93] [Article Influence: 9.4] [Reference Citation Analysis]
102 Nguyen A, Bhavsar S, Riley E, Caponetti G, Agrawal D. Clinical Value of High Mobility Group Box 1 and the Receptor for Advanced Glycation End-products in Head and Neck Cancer: A Systematic Review. Int Arch Otorhinolaryngol 2016;20:382-9. [PMID: 27746844 DOI: 10.1055/s-0036-1583168] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
103 Lolmede K, Campana L, Vezzoli M, Bosurgi L, Tonlorenzi R, Clementi E, Bianchi ME, Cossu G, Manfredi AA, Brunelli S, Rovere-Querini P. Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways. J Leukoc Biol. 2009;85:779-787. [PMID: 19197071 DOI: 10.1189/jlb.0908579] [Cited by in Crossref: 154] [Cited by in F6Publishing: 155] [Article Influence: 11.8] [Reference Citation Analysis]
104 Konermann A, Stabenow D, Knolle PA, Held SA, Deschner J, Jäger A. Regulatory role of periodontal ligament fibroblasts for innate immune cell function and differentiation. Innate Immun 2012;18:745-52. [PMID: 22436844 DOI: 10.1177/1753425912440598] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
105 Hasegawa T, Ikeda S; Department of Dermatology and Allergology, Juntendo University Graduate School of Medicine, Tokyo, Japan. . AIMS Cell and Tissue Engineering 2017;1:104-17. [DOI: 10.3934/celltissue.2017.2.104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
106 Ranzato E, Patrone M, Pedrazzi M, Burlando B. Hmgb1 promotes wound healing of 3T3 mouse fibroblasts via RAGE-dependent ERK1/2 activation. Cell Biochem Biophys 2010;57:9-17. [PMID: 20361273 DOI: 10.1007/s12013-010-9077-0] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 4.7] [Reference Citation Analysis]
107 Chen R, Hou W, Zhang Q, Kang R, Fan XG, Tang D. Emerging role of high-mobility group box 1 (HMGB1) in liver diseases. Mol Med. 2013;19:357-366. [PMID: 24306421 DOI: 10.2119/molmed.2013.00099] [Cited by in Crossref: 50] [Cited by in F6Publishing: 62] [Article Influence: 5.6] [Reference Citation Analysis]
108 Ratliff BB, Rabadi MM, Vasko R, Yasuda K, Goligorsky MS. Messengers without borders: mediators of systemic inflammatory response in AKI. J Am Soc Nephrol 2013;24:529-36. [PMID: 23349311 DOI: 10.1681/ASN.2012060633] [Cited by in Crossref: 62] [Cited by in F6Publishing: 41] [Article Influence: 6.9] [Reference Citation Analysis]
109 Trensz F, Haroun S, Cloutier A, Richter MV, Grenier G. A muscle resident cell population promotes fibrosis in hindlimb skeletal muscles of mdx mice through the Wnt canonical pathway. Am J Physiol Cell Physiol 2010;299:C939-47. [PMID: 20810909 DOI: 10.1152/ajpcell.00253.2010] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 4.2] [Reference Citation Analysis]
110 Ebe N, Hara-Yokoyama M, Iwasaki K, Iseki S, Okuhara S, Podyma-Inoue KA, Terasawa K, Watanabe A, Akizuki T, Watanabe H, Yanagishita M, Izumi Y. Pocket epithelium in the pathological setting for HMGB1 release. J Dent Res 2011;90:235-40. [PMID: 21149855 DOI: 10.1177/0022034510385688] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
111 Moyle LA, Tedesco FS, Benedetti S. Pericytes in Muscular Dystrophies. Adv Exp Med Biol 2019;1147:319-44. [PMID: 31147885 DOI: 10.1007/978-3-030-16908-4_15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
112 Biscetti F, Flex A, Pecorini G, Angelini F, Arena V, Stigliano E, Gremese E, Tolusso B, Ferraccioli G. The role of high-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on vascular endothelial growth factor. Clin Exp Immunol 2016;184:62-72. [PMID: 26671547 DOI: 10.1111/cei.12758] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
113 Yang Q, Jia C, Wang P, Xiong M, Cui J, Li L, Wang W, Wu Q, Chen Y, Zhang T. MicroRNA-505 identified from patients with essential hypertension impairs endothelial cell migration and tube formation. Int J Cardiol 2014;177:925-34. [PMID: 25449503 DOI: 10.1016/j.ijcard.2014.09.204] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 6.8] [Reference Citation Analysis]
114 Smolarczyk R, Cichoń T, Matuszczak S, Mitrus I, Lesiak M, Kobusińska M, Kamysz W, Jarosz M, Sieroń A, Szala S. The Role of Glycyrrhizin, an Inhibitor of HMGB1 Protein, in Anticancer Therapy. Arch Immunol Ther Exp 2012;60:391-9. [DOI: 10.1007/s00005-012-0183-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
115 Chudziak D, Sireis W, Pfeiffer H, Henschler R, Seifried E, Bönig H. Accumulation of soluble inflammatory mediators between blood donation and pre-storage leucocyte depletion. Vox Sanguinis 2009;96:163-6. [DOI: 10.1111/j.1423-0410.2008.01132.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
116 Ito T, Kawahara K, Nakamura T, Yamada S, Nakamura T, Abeyama K, Hashiguchi T, Maruyama I. High-mobility group box 1 protein promotes development of microvascular thrombosis in rats. J Thromb Haemost. 2007;5:109-116. [PMID: 17239166 DOI: 10.1111/j.1538-7836.2006.02255.x] [Cited by in Crossref: 121] [Cited by in F6Publishing: 110] [Article Influence: 8.1] [Reference Citation Analysis]
117 Ferhani N, Letuve S, Kozhich A, Thibaudeau O, Grandsaigne M, Maret M, Dombret MC, Sims GP, Kolbeck R, Coyle AJ, Aubier M, Pretolani M. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;181:917-27. [PMID: 20133931 DOI: 10.1164/rccm.200903-0340OC] [Cited by in Crossref: 138] [Cited by in F6Publishing: 78] [Article Influence: 11.5] [Reference Citation Analysis]
118 Festoff BW, Sajja RK, Cucullo L. Proximate Mediators of Microvascular Dysfunction at the Blood-Brain Barrier: Neuroinflammatory Pathways to Neurodegeneration. Biomed Res Int 2017;2017:1549194. [PMID: 28890893 DOI: 10.1155/2017/1549194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
119 Rojas A, Pérez-Castro R, González I, Delgado F, Romero J, Rojas I. The emerging role of the receptor for advanced glycation end products on innate immunity. Int Rev Immunol 2014;33:67-80. [PMID: 24266871 DOI: 10.3109/08830185.2013.849702] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
120 Candolfi M, Yagiz K, Foulad D, Alzadeh GE, Tesarfreund M, Muhammad AK, Puntel M, Kroeger KM, Liu C, Lee S, Curtin JF, King GD, Lerner J, Sato K, Mineharu Y, Xiong W, Lowenstein PR, Castro MG. Release of HMGB1 in response to proapoptotic glioma killing strategies: efficacy and neurotoxicity. Clin Cancer Res 2009;15:4401-14. [PMID: 19570774 DOI: 10.1158/1078-0432.CCR-09-0155] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
121 Huan CC, Wang HX, Sheng XX, Wang R, Wang X, Mao X. Glycyrrhizin inhibits porcine epidemic diarrhea virus infection and attenuates the proinflammatory responses by inhibition of high mobility group box-1 protein. Arch Virol 2017;162:1467-76. [PMID: 28175983 DOI: 10.1007/s00705-017-3259-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
122 Pattison CJ, Korolchuk VI. Autophagy: ‘Self-Eating’ Your Way to Longevity. In: Harris JR, Korolchuk VI, editors. Biochemistry and Cell Biology of Ageing: Part I Biomedical Science. Singapore: Springer; 2018. pp. 25-47. [DOI: 10.1007/978-981-13-2835-0_2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
123 Wang L, Kamath A, Frye J, Iwamoto GA, Chun JL, Berry SE. Aorta-derived mesoangioblasts differentiate into the oligodendrocytes by inhibition of the Rho kinase signaling pathway. Stem Cells Dev 2012;21:1069-89. [PMID: 21793703 DOI: 10.1089/scd.2011.0124] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
124 Sitia G, Iannacone M, Müller S, Bianchi ME, Guidotti LG. Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice. J Leukoc Biol. 2007;81:100-107. [PMID: 16935945 DOI: 10.1189/jlb.0306173] [Cited by in Crossref: 94] [Cited by in F6Publishing: 96] [Article Influence: 5.9] [Reference Citation Analysis]
125 Penzo M, Molteni R, Suda T, Samaniego S, Raucci A, Habiel DM, Miller F, Jiang HP, Li J, Pardi R, Palumbo R, Olivotto E, Kew RR, Bianchi ME, Marcu KB. Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis [corrected]. J Immunol. 2010;184:4497-4509. [PMID: 20231695 DOI: 10.4049/jimmunol.0903131] [Cited by in Crossref: 72] [Cited by in F6Publishing: 71] [Article Influence: 6.0] [Reference Citation Analysis]
126 Xu J, Benabou K, Cui X, Madia M, Tzeng E, Billiar T, Watkins S, Sachdev U. TLR4 Deters Perfusion Recovery and Upregulates Toll-like Receptor 2 (TLR2) in Ischemic Skeletal Muscle and Endothelial Cells. Mol Med 2015;21:605-15. [PMID: 26181630 DOI: 10.2119/molmed.2014.00260] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
127 Ceafalan LC, Popescu BO, Hinescu ME. Cellular players in skeletal muscle regeneration. Biomed Res Int 2014;2014:957014. [PMID: 24779022 DOI: 10.1155/2014/957014] [Cited by in Crossref: 73] [Cited by in F6Publishing: 67] [Article Influence: 9.1] [Reference Citation Analysis]
128 Zeh HJ 3rd, Lotze MT. Addicted to death: invasive cancer and the immune response to unscheduled cell death. J Immunother 2005;28:1-9. [PMID: 15614039 DOI: 10.1097/00002371-200501000-00001] [Cited by in Crossref: 110] [Cited by in F6Publishing: 102] [Article Influence: 6.5] [Reference Citation Analysis]
129 Dahlin K, Mager EM, Allen L, Tigue Z, Goodglick L, Wadehra M, Dobbs L. Identification of genes differentially expressed in rat alveolar type I cells. Am J Respir Cell Mol Biol 2004;31:309-16. [PMID: 15205179 DOI: 10.1165/rcmb.2003-0423OC] [Cited by in Crossref: 85] [Cited by in F6Publishing: 52] [Article Influence: 4.7] [Reference Citation Analysis]
130 Careccia G, Saclier M, Tirone M, Ruggieri E, Principi E, Raffaghello L, Torchio S, Recchia D, Canepari M, Gorzanelli A, Ferrara M, Castellani P, Rubartelli A, Rovere-Querini P, Casalgrandi M, Preti A, Lorenzetti I, Bruno C, Bottinelli R, Brunelli S, Previtali SC, Bianchi ME, Messina G, Vénéreau E. Rebalancing expression of HMGB1 redox isoforms to counteract muscular dystrophy. Sci Transl Med 2021;13:eaay8416. [PMID: 34078746 DOI: 10.1126/scitranslmed.aay8416] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
131 Wang H, Zhu S, Zhou R, Li W, Sama AE. Therapeutic potential of HMGB1-targeting agents in sepsis. Expert Rev Mol Med 2008;10:e32. [PMID: 18980707 DOI: 10.1017/S1462399408000884] [Cited by in Crossref: 75] [Cited by in F6Publishing: 55] [Article Influence: 5.4] [Reference Citation Analysis]
132 Flohé SB, Flohé S, Schade FU. Invited review: deterioration of the immune system after trauma: signals and cellular mechanisms. Innate Immun 2008;14:333-44. [PMID: 19039057 DOI: 10.1177/1753425908100016] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 4.6] [Reference Citation Analysis]
133 Prêle CM, Woodward EA, Bisley J, Keith-Magee A, Nicholson SE, Hart PH. SOCS1 regulates the IFN but not NFkappaB pathway in TLR-stimulated human monocytes and macrophages. J Immunol 2008;181:8018-26. [PMID: 19017994 DOI: 10.4049/jimmunol.181.11.8018] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
134 Altmann S, Lange S, Pommerencke J, Murua Escobar H, Bullerdiek J, Nolte I, Freund M, Junghanss C. High Mobility Group Box 1-Protein expression in canine haematopoietic cells and influence on canine peripheral blood mononuclear cell proliferative activity. Vet Immunol Immunopathol 2008;126:367-72. [PMID: 18762340 DOI: 10.1016/j.vetimm.2008.07.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
135 Manfredi AA, Sabbadini MG, Rovere-Querini P. Dendritic cells and the shadow line between autoimmunity and disease. Arthritis Rheum 2005;52:11-5. [PMID: 15641071 DOI: 10.1002/art.20758] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
136 Candela ME, Geraci F, Turturici G, Taverna S, Albanese I, Sconzo G. Membrane vesicles containing matrix metalloproteinase-9 and fibroblast growth factor-2 are released into the extracellular space from mouse mesoangioblast stem cells. J Cell Physiol 2010;224:144-51. [PMID: 20232295 DOI: 10.1002/jcp.22111] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
137 Sadamura-Takenaka Y, Ito T, Noma S, Oyama Y, Yamada S, Kawahara K, Inoue H, Maruyama I. HMGB1 promotes the development of pulmonary arterial hypertension in rats. PLoS One 2014;9:e102482. [PMID: 25032709 DOI: 10.1371/journal.pone.0102482] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
138 Vacas S, Degos V, Tracey KJ, Maze M. High-mobility group box 1 protein initiates postoperative cognitive decline by engaging bone marrow-derived macrophages. Anesthesiology 2014;120:1160-7. [PMID: 24162463 DOI: 10.1097/ALN.0000000000000045] [Cited by in Crossref: 87] [Cited by in F6Publishing: 50] [Article Influence: 10.9] [Reference Citation Analysis]
139 Schäfer R, Dominici M, Müller I, Horwitz E, Asahara T, Bulte JW, Bieback K, Le Blanc K, Bühring HJ, Capogrossi MC, Dazzi F, Gorodetsky R, Henschler R, Handgretinger R, Kajstura J, Kluger PJ, Lange C, Luettichau Iv, Mertsching H, Schrezenmeier H, Sievert KD, Strunk D, Verfaillie C, Northoff H. Basic research and clinical applications of non-hematopoietic stem cells, 4-5 April 2008, Tubingen, Germany. Cytotherapy 2009;11:245-55. [PMID: 19152153 DOI: 10.1080/14653240802582117] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
140 Volz HC, Seidel C, Laohachewin D, Kaya Z, Müller OJ, Pleger ST, Lasitschka F, Bianchi ME, Remppis A, Bierhaus A, Katus HA, Andrassy M. HMGB1: the missing link between diabetes mellitus and heart failure. Basic Res Cardiol 2010;105:805-20. [PMID: 20703492 DOI: 10.1007/s00395-010-0114-3] [Cited by in Crossref: 76] [Cited by in F6Publishing: 79] [Article Influence: 6.3] [Reference Citation Analysis]
141 Gordon O, Reis e Sousa C. Cytoskeletal Exposure in the Regulation of Immunity and Initiation of Tissue Repair. Bioessays 2019;41:e1900021. [PMID: 31157930 DOI: 10.1002/bies.201900021] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
142 Klune JR, Billiar TR, Tsung A. HMGB1 preconditioning: therapeutic application for a danger signal? J Leukoc Biol 2008;83:558-63. [PMID: 17938274 DOI: 10.1189/jlb.0607406] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
143 Tancharoen S, Gando S, Binita S, Nagasato T, Kikuchi K, Nawa Y, Dararat P, Yamamoto M, Narkpinit S, Maruyama I. HMGB1 Promotes Intraoral Palatal Wound Healing through RAGE-Dependent Mechanisms. Int J Mol Sci 2016;17:E1961. [PMID: 27886093 DOI: 10.3390/ijms17111961] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
144 Kawahara K, Setoyama K, Kikuchi K, Biswas KK, Kamimura R, Iwata M, Ito T, Morimoto Y, Hashiguchi T, Takao S, Maruyama I. HMGB1 release in co-cultures of porcine endothelial and human T cells. Xenotransplantation 2007;14:636-41. [PMID: 17991152 DOI: 10.1111/j.1399-3089.2007.00434.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
145 Zhou YH, Han QF, Gao L, Sun Y, Tang ZW, Wang M, Wang W, Yao HC. HMGB1 Protects the Heart Against Ischemia-Reperfusion Injury via PI3K/AkT Pathway-Mediated Upregulation of VEGF Expression. Front Physiol 2019;10:1595. [PMID: 32063860 DOI: 10.3389/fphys.2019.01595] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
146 Rabadi MM, Ghaly T, Goligorksy MS, Ratliff BB. HMGB1 in renal ischemic injury. Am J Physiol Renal Physiol 2012;303:F873-85. [PMID: 22759395 DOI: 10.1152/ajprenal.00092.2012] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
147 Mollica L, De Marchis F, Spitaleri A, Dallacosta C, Pennacchini D, Zamai M, Agresti A, Trisciuoglio L, Musco G, Bianchi ME. Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. Chem Biol. 2007;14:431-441. [PMID: 17462578 DOI: 10.1016/j.chembiol.2007.03.007] [Cited by in Crossref: 339] [Cited by in F6Publishing: 332] [Article Influence: 22.6] [Reference Citation Analysis]
148 Akhmedov AT, Marín-García J. Myocardial regeneration of the failing heart. Heart Fail Rev 2013;18:815-33. [PMID: 23001638 DOI: 10.1007/s10741-012-9348-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
149 Kuleš J, Gotić J, Mrljak V, Barić Rafaj R. Blood markers of fibrinolysis and endothelial activation in canine babesiosis. BMC Vet Res 2017;13:82. [PMID: 28363279 DOI: 10.1186/s12917-017-0995-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
150 Kido T, Miyagawa S, Goto T, Tamai K, Ueno T, Toda K, Kuratani T, Sawa Y. The administration of high-mobility group box 1 fragment prevents deterioration of cardiac performance by enhancement of bone marrow mesenchymal stem cell homing in the delta-sarcoglycan-deficient hamster. PLoS One 2018;13:e0202838. [PMID: 30517097 DOI: 10.1371/journal.pone.0202838] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
151 Hongo K, Kazama S, Tsuno NH, Ishihara S, Sunami E, Kitayama J, Watanabe T. Immunohistochemical detection of high-mobility group box 1 correlates with resistance of preoperative chemoradiotherapy for lower rectal cancer: a retrospective study. World J Surg Oncol 2015;13:7. [PMID: 25622595 DOI: 10.1186/1477-7819-13-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
152 Pittet JF, Koh H, Fang X, Iles K, Christiaans S, Anjun N, Wagener BM, Park DW, Zmijewski JW, Matthay MA, Roux J. HMGB1 accelerates alveolar epithelial repair via an IL-1β- and αvβ6 integrin-dependent activation of TGF-β1. PLoS One 2013;8:e63907. [PMID: 23696858 DOI: 10.1371/journal.pone.0063907] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
153 Li W, Sama AE, Wang H. Role of HMGB1 in cardiovascular diseases. Curr Opin Pharmacol 2006;6:130-5. [PMID: 16487750 DOI: 10.1016/j.coph.2005.10.010] [Cited by in Crossref: 81] [Cited by in F6Publishing: 85] [Article Influence: 5.1] [Reference Citation Analysis]
154 Zhang J, Wang J, Wu X, Wei Y. Ginsenoside Rb1 inhibits proliferation and promotes apoptosis by regulating HMGB1 in uterine fibroid cells. Artif Cells Nanomed Biotechnol 2019;47:2967-71. [PMID: 31313594 DOI: 10.1080/21691401.2019.1643732] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
155 Wang H, Ward MF, Sama AE. Novel HMGB1-inhibiting therapeutic agents for experimental sepsis. Shock. 2009;32:348-357. [PMID: 19333143 DOI: 10.1097/SHK.0b013e3181a551bd] [Cited by in Crossref: 87] [Cited by in F6Publishing: 50] [Article Influence: 7.3] [Reference Citation Analysis]
156 Zurolo E, Iyer A, Maroso M, Carbonell C, Anink JJ, Ravizza T, Fluiter K, Spliet WG, van Rijen PC, Vezzani A, Aronica E. Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development. Brain 2011;134:1015-32. [PMID: 21414994 DOI: 10.1093/brain/awr032] [Cited by in Crossref: 134] [Cited by in F6Publishing: 136] [Article Influence: 12.2] [Reference Citation Analysis]
157 Yang PS, Kim DH, Lee YJ, Lee SE, Kang WJ, Chang HJ, Shin JS. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats. Respir Res 2014;15:148. [PMID: 25420924 DOI: 10.1186/s12931-014-0148-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
158 van Beijnum JR, Buurman WA, Griffioen AW. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis. 2008;11:91-99. [PMID: 18264787 DOI: 10.1007/s10456-008-9093-5] [Cited by in Crossref: 315] [Cited by in F6Publishing: 331] [Article Influence: 22.5] [Reference Citation Analysis]
159 He SJ, Cheng J, Feng X, Yu Y, Tian L, Huang Q. The dual role and therapeutic potential of high-mobility group box 1 in cancer. Oncotarget 2017;8:64534-50. [PMID: 28969092 DOI: 10.18632/oncotarget.17885] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 11.8] [Reference Citation Analysis]
160 Musumeci D, Bucci EM, Roviello GN, Sapio R, Valente M, Moccia M, Bianchi ME, Pedone C. DNA-based strategies for blocking HMGB1 cytokine activity: design, synthesis and preliminary in vitro/in vivo assays of DNA and DNA-like duplexes. Mol Biosyst 2011;7:1742-52. [PMID: 21431162 DOI: 10.1039/c1mb05009e] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
161 Xu J, Sachdev U. The Toll of Vascular Insufficiency: Implications for the Management of Peripheral Arterial Disease. J Immunol Res 2016;2016:8249015. [PMID: 26998496 DOI: 10.1155/2016/8249015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
162 Charoonpatrapong K, Shah R, Robling AG, Alvarez M, Clapp DW, Chen S, Kopp RP, Pavalko FM, Yu J, Bidwell JP. HMGB1 expression and release by bone cells. J Cell Physiol 2006;207:480-90. [PMID: 16419037 DOI: 10.1002/jcp.20577] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 2.8] [Reference Citation Analysis]
163 Di X, He G, Chen H, Zhu C, Qin Q, Yan J, Zhang X, Sun X. High-mobility group box 1 protein modulated proliferation and radioresistance in esophageal squamous cell carcinoma. J Gastroenterol Hepatol 2019;34:728-35. [PMID: 29968320 DOI: 10.1111/jgh.14371] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
164 Díaz-Manera J, Gallardo E, de Luna N, Navas M, Soria L, Garibaldi M, Rojas-García R, Tonlorenzi R, Cossu G, Illa I. The increase of pericyte population in human neuromuscular disorders supports their role in muscle regeneration in vivo. J Pathol 2012;228:544-53. [PMID: 22847756 DOI: 10.1002/path.4083] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
165 Krysko O, Løve Aaes T, Bachert C, Vandenabeele P, Krysko DV. Many faces of DAMPs in cancer therapy. Cell Death Dis 2013;4:e631. [PMID: 23681226 DOI: 10.1038/cddis.2013.156] [Cited by in Crossref: 150] [Cited by in F6Publishing: 142] [Article Influence: 16.7] [Reference Citation Analysis]
166 Panzarini E, Inguscio V, Dini L. Immunogenic cell death: can it be exploited in PhotoDynamic Therapy for cancer? Biomed Res Int 2013;2013:482160. [PMID: 23509727 DOI: 10.1155/2013/482160] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 6.0] [Reference Citation Analysis]
167 Di Caro V, Walko TD 3rd, Bola RA, Hong JD, Pang D, Hsue V, Au AK, Halstead ES, Carcillo JA, Clark RS, Aneja RK. Plasma Mitochondrial DNA--a Novel DAMP in Pediatric Sepsis. Shock 2016;45:506-11. [PMID: 26682947 DOI: 10.1097/SHK.0000000000000539] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 5.2] [Reference Citation Analysis]
168 Griffin CA, Apponi LH, Long KK, Pavlath GK. Chemokine expression and control of muscle cell migration during myogenesis. J Cell Sci 2010;123:3052-60. [PMID: 20736301 DOI: 10.1242/jcs.066241] [Cited by in Crossref: 98] [Cited by in F6Publishing: 94] [Article Influence: 8.2] [Reference Citation Analysis]
169 Li NY, Lee BJ, Thibeault SL. Temporal and spatial expression of high-mobility group box 1 in surgically injured rat vocal folds. Laryngoscope 2012;122:364-9. [PMID: 22252485 DOI: 10.1002/lary.22435] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
170 Ismail AA, Wagner S, Murua Escobar H, Willenbrock S, Sterenczak KA, Samy MT, Abd El-Aal AM, Nolte I, Wefstaedt P. Effects of high-mobility group a protein application on canine adipose-derived mesenchymal stem cells in vitro. Vet Med Int 2012;2012:752083. [PMID: 22448338 DOI: 10.1155/2012/752083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
171 Sancricca C, Mirabella M, Gliubizzi C, Broccolini A, Gidaro T, Morosetti R. Vessel-associated stem cells from skeletal muscle: From biology to future uses in cell therapy. World J Stem Cells 2010; 2(3): 39-49 [PMID: 21607121 DOI: 10.4252/wjsc.v2.i3.39] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
172 Raman KG, Sappington PL, Yang R, Levy RM, Prince JM, Liu S, Watkins SK, Schmidt AM, Billiar TR, Fink MP. The role of RAGE in the pathogenesis of intestinal barrier dysfunction after hemorrhagic shock. Am J Physiol Gastrointest Liver Physiol 2006;291:G556-65. [PMID: 16751175 DOI: 10.1152/ajpgi.00055.2006] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 2.7] [Reference Citation Analysis]
173 Díaz-Manera J, Touvier T, Dellavalle A, Tonlorenzi R, Tedesco FS, Messina G, Meregalli M, Navarro C, Perani L, Bonfanti C, Illa I, Torrente Y, Cossu G. Partial dysferlin reconstitution by adult murine mesoangioblasts is sufficient for full functional recovery in a murine model of dysferlinopathy. Cell Death Dis 2010;1:e61. [PMID: 21364666 DOI: 10.1038/cddis.2010.35] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
174 Wähämaa H, Vallerskog T, Qin S, Lunderius C, Larosa G, Andersson U, Harris HE. HMGB1-secreting capacity of multiple cell lineages revealed by a novel HMGB1 ELISPOT assay. Journal of Leukocyte Biology 2007;81:129-36. [DOI: 10.1189/jlb.0506349] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 2.0] [Reference Citation Analysis]
175 Zhang X, Jiang H, Gong Q, Fan C, Huang Y, Ling J. Expression of high mobility group box 1 in inflamed dental pulp and its chemotactic effect on dental pulp cells. Biochem Biophys Res Commun 2014;450:1547-52. [PMID: 25019990 DOI: 10.1016/j.bbrc.2014.07.027] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
176 Kim SJ, Ryu MJ, Han J, Jang Y, Lee MJ, Ju X, Ryu I, Lee YL, Oh E, Chung W, Heo JY, Kweon GR. Non-cell autonomous modulation of tyrosine hydroxylase by HMGB1 released from astrocytes in an acute MPTP-induced Parkinsonian mouse model. Lab Invest 2019;99:1389-99. [PMID: 31043679 DOI: 10.1038/s41374-019-0254-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
177 Asadzadeh Z, Safarzadeh E, Safaei S, Baradaran A, Mohammadi A, Hajiasgharzadeh K, Derakhshani A, Argentiero A, Silvestris N, Baradaran B. Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell Death. Cancers (Basel) 2020;12:E1047. [PMID: 32340275 DOI: 10.3390/cancers12041047] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 15.5] [Reference Citation Analysis]
178 Wang H, Li Z, Sun Y, Xu Z, Han J, Song B, Song W, Qin C, Yin L. Relationship between high-mobility group box 1 overexpression in ovarian cancer tissue and serum: a meta-analysis. Onco Targets Ther 2015;8:3523-31. [PMID: 26664135 DOI: 10.2147/OTT.S93357] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
179 Shang G, Jia C, Tian H, Xiao W, Li Y, Wang A, Dong L, Lin D. Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer. Respiratory Medicine 2009;103:1949-53. [DOI: 10.1016/j.rmed.2009.05.019] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 4.1] [Reference Citation Analysis]
180 Xiang M, Yuan Y, Fan L, Li Y, Li A, Yin L, Scott MJ, Xiao G, Billiar TR, Wilson MA, Fan J. Role of macrophages in mobilization of hematopoietic progenitor cells from bone marrow after hemorrhagic shock. Shock 2012;37:518-23. [PMID: 22293600 DOI: 10.1097/SHK.0b013e318249b81d] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
181 Musumeci D, Roviello GN, Montesarchio D, Sapio R, Valente M, Anrò V, Bucci EM. Hairpin ODN-based ligands as potential inhibitors of HMGB1 cytokine activity. RSC Adv 2013;3:12176. [DOI: 10.1039/c3ra41915k] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
182 Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol. 2007;81:1-5. [PMID: 17032697 DOI: 10.1189/jlb.0306164] [Cited by in Crossref: 1816] [Cited by in F6Publishing: 1725] [Article Influence: 113.5] [Reference Citation Analysis]
183 Miura K, Sahara H, Sekijima M, Kawai A, Waki S, Nishimura H, Setoyama K, Clayman ES, Shimizu A, Yamada K. Protective effect of neutralization of the extracellular high-mobility group box 1 on renal ischemia-reperfusion injury in miniature swine. Transplantation 2014;98:937-43. [PMID: 25136847 DOI: 10.1097/TP.0000000000000358] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
184 Hu Y, Yan R, Zhang C, Zhou Z, Liu M, Wang C, Zhang H, Dong L, Zhou T, Wu Y, Dong N, Wu Q. High-Mobility Group Box 1 From Hypoxic Trophoblasts Promotes Endothelial Microparticle Production and Thrombophilia in Preeclampsia. Arterioscler Thromb Vasc Biol 2018;38:1381-91. [PMID: 29650693 DOI: 10.1161/ATVBAHA.118.310940] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
185 Wang H, Ward MF, Fan XG, Sama AE, Li W. Potential role of high mobility group box 1 in viral infectious diseases. Viral Immunol. 2006;19:3-9. [PMID: 16553546 DOI: 10.1089/vim.2006.19.3] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 3.5] [Reference Citation Analysis]
186 Hayakawa K, Pham LD, Arai K, Lo EH. High-mobility group box 1: an amplifier of stem and progenitor cell activity after stroke. Acta Neurochir Suppl 2013;118:31-8. [PMID: 23564100 DOI: 10.1007/978-3-7091-1434-6_5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
187 Holmlund U, Wähämaa H, Bachmayer N, Bremme K, Sverremark-Ekström E, Palmblad K. The novel inflammatory cytokine high mobility group box protein 1 (HMGB1) is expressed by human term placenta. Immunology 2007;122:430-7. [PMID: 17617154 DOI: 10.1111/j.1365-2567.2007.02662.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 4.0] [Reference Citation Analysis]
188 Bianchi ME, Crippa MP, Manfredi AA, Mezzapelle R, Rovere Querini P, Venereau E. High-mobility group box 1 protein orchestrates responses to tissue damage via inflammation, innate and adaptive immunity, and tissue repair. Immunol Rev 2017;280:74-82. [PMID: 29027228 DOI: 10.1111/imr.12601] [Cited by in Crossref: 130] [Cited by in F6Publishing: 128] [Article Influence: 32.5] [Reference Citation Analysis]
189 Yin H, Price F, Rudnicki MA. Satellite cells and the muscle stem cell niche. Physiol Rev. 2013;93:23-67. [PMID: 23303905 DOI: 10.1152/physrev.00043.2011] [Cited by in Crossref: 963] [Cited by in F6Publishing: 895] [Article Influence: 107.0] [Reference Citation Analysis]
190 Furlani D, Donndorf P, Westien I, Ugurlucan M, Pittermann E, Wang W, Li W, Vollmar B, Steinhoff G, Kaminski A, Ma N. HMGB-1 induces c-kit+ cell microvascular rolling and adhesion via both toll-like receptor-2 and toll-like receptor-4 of endothelial cells. J Cell Mol Med 2012;16:1094-105. [PMID: 21762373 DOI: 10.1111/j.1582-4934.2011.01381.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
191 Yaser AM, Huang Y, Zhou RR, Hu GS, Xiao MF, Huang ZB, Duan CJ, Tian W, Tang DL, Fan XG. The Role of receptor for Advanced Glycation End Products (RAGE) in the proliferation of hepatocellular carcinoma. Int J Mol Sci. 2012;13:5982-5997. [PMID: 22754344 DOI: 10.3390/ijms13055982] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
192 Kornblit B, Masmas T, Petersen SL, Madsen HO, Heilmann C, Schejbel L, Sengeløv H, Müller K, Garred P, Vindeløv L. Association of HMGB1 polymorphisms with outcome after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2010;16:239-252. [PMID: 19819342 DOI: 10.1016/j.bbmt.2009.10.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 3.2] [Reference Citation Analysis]
193 Berry SE, Liu J, Chaney EJ, Kaufman SJ. Multipotential mesoangioblast stem cell therapy in the mdx/utrn -/- mouse model for Duchenne muscular dystrophy. Regenerative Medicine 2007;2:275-88. [DOI: 10.2217/17460751.2.3.275] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
194 Lv Y, Lin C. High mobility group box 1-immobilized nanofibrous scaffold enhances vascularization, osteogenesis and stem cell recruitment. J Mater Chem B 2016;4:5002-14. [DOI: 10.1039/c6tb00826g] [Cited by in Crossref: 6] [Article Influence: 1.0] [Reference Citation Analysis]
195 Wang D, Gilbert JR, Zhang X, Zhao B, Ker DFE, Cooper GM. Calvarial Versus Long Bone: Implications for Tailoring Skeletal Tissue Engineering. Tissue Eng Part B Rev 2020;26:46-63. [PMID: 31588853 DOI: 10.1089/ten.TEB.2018.0353] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
196 Frangogiannis NG. The Inflammatory Response in Tissue Repair. Inflammation - From Molecular and Cellular Mechanisms to the Clinic. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2017. pp. 1517-38. [DOI: 10.1002/9783527692156.ch60] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
197 Heinola T, Sukura A, Virkki LM, Sillat T, Lekszycki T, Konttinen YT. Osteoarthritic cartilage lesions in the bovine patellar groove: a macroscopic, histological and immunohistological analysis. Vet J 2014;200:88-95. [PMID: 24581814 DOI: 10.1016/j.tvjl.2014.01.026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
198 Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao L, Huang J, Yu Y, Fan XG, Yan Z, Sun X, Wang H, Wang Q, Tsung A, Billiar TR, Zeh HJ 3rd, Lotze MT, Tang D. HMGB1 in health and disease. Mol Aspects Med 2014;40:1-116. [PMID: 25010388 DOI: 10.1016/j.mam.2014.05.001] [Cited by in Crossref: 445] [Cited by in F6Publishing: 443] [Article Influence: 55.6] [Reference Citation Analysis]
199 Candolfi M, King GD, Yagiz K, Curtin JF, Mineharu Y, Muhammad AK, Foulad D, Kroeger KM, Barnett N, Josien R, Lowenstein PR, Castro MG. Plasmacytoid dendritic cells in the tumor microenvironment: immune targets for glioma therapeutics. Neoplasia 2012;14:757-70. [PMID: 22952428 DOI: 10.1593/neo.12794] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
200 Blaauw B, Reggiani C. The role of satellite cells in muscle hypertrophy. J Muscle Res Cell Motil 2014;35:3-10. [DOI: 10.1007/s10974-014-9376-y] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 5.5] [Reference Citation Analysis]
201 Raucci A, Di Maggio S, Scavello F, D'Ambrosio A, Bianchi ME, Capogrossi MC. The Janus face of HMGB1 in heart disease: a necessary update. Cell Mol Life Sci. 2019;76:211-229. [PMID: 30306212 DOI: 10.1007/s00018-018-2930-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 9.3] [Reference Citation Analysis]
202 Chirico V, Lacquaniti A, Salpietro V, Munafò C, Calabrò MP, Buemi M, Arrigo T, Salpietro C. High-mobility group box 1 (HMGB1) in childhood: from bench to bedside. Eur J Pediatr. 2014;173:1123-1136. [PMID: 24809802 DOI: 10.1007/s00431-014-2327-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
203 Pusterla T, de Marchis F, Palumbo R, Bianchi ME. High mobility group B2 is secreted by myeloid cells and has mitogenic and chemoattractant activities similar to high mobility group B1: Brief definite report. Autoimmunity 2009;42:308-10. [DOI: 10.1080/08916930902831845] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
204 Tang JB, Goellner EM, Wang XH, Trivedi RN, St Croix CM, Jelezcova E, Svilar D, Brown AR, Sobol RW. Bioenergetic metabolites regulate base excision repair-dependent cell death in response to DNA damage. Mol Cancer Res 2010;8:67-79. [PMID: 20068071 DOI: 10.1158/1541-7786.MCR-09-0411] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
205 Chavakis E, Hain A, Vinci M, Carmona G, Bianchi ME, Vajkoczy P, Zeiher AM, Chavakis T, Dimmeler S. High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ Res. 2007;100:204-212. [PMID: 17218606 DOI: 10.1161/01.res.0000257774.55970.f4] [Cited by in Crossref: 227] [Cited by in F6Publishing: 113] [Article Influence: 15.1] [Reference Citation Analysis]
206 Yamamoto T, Tajima Y. HMGB1 is a promising therapeutic target for acute liver failure. Expert Rev Gastroenterol Hepatol 2017;11:673-82. [PMID: 28657371 DOI: 10.1080/17474124.2017.1345625] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
207 Ogawa N, Nakajima S, Tamada K, Yokoue N, Tachibana H, Okazawa M, Oyama T, Abe H, Yamazaki H, Yoshimori A, Sato A, Kamiya T, Yokomizo T, Uchiumi F, Abe T, Tanuma SI. Trimebutine suppresses Toll-like receptor 2/4/7/8/9 signaling pathways in macrophages. Arch Biochem Biophys 2021;711:109029. [PMID: 34517011 DOI: 10.1016/j.abb.2021.109029] [Reference Citation Analysis]
208 Rossini A, Zacheo A, Mocini D, Totta P, Facchiano A, Castoldi R, Sordini P, Pompilio G, Abeni D, Capogrossi MC, Germani A. HMGB1-stimulated human primary cardiac fibroblasts exert a paracrine action on human and murine cardiac stem cells. Journal of Molecular and Cellular Cardiology 2008;44:683-93. [DOI: 10.1016/j.yjmcc.2008.01.009] [Cited by in Crossref: 85] [Cited by in F6Publishing: 79] [Article Influence: 6.1] [Reference Citation Analysis]
209 Zhu X, Yao Y, Liang H, Liu F, Dong N, Yu Y, Sheng Z. Effect of high mobility group box-1 protein on apoptosis of peritoneal macrophages. Archives of Biochemistry and Biophysics 2009;492:54-61. [DOI: 10.1016/j.abb.2009.09.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
210 Limana F, Esposito G, D'Arcangelo D, Di Carlo A, Romani S, Melillo G, Mangoni A, Bertolami C, Pompilio G, Germani A, Capogrossi MC. HMGB1 attenuates cardiac remodelling in the failing heart via enhanced cardiac regeneration and miR-206-mediated inhibition of TIMP-3. PLoS One 2011;6:e19845. [PMID: 21731608 DOI: 10.1371/journal.pone.0019845] [Cited by in Crossref: 89] [Cited by in F6Publishing: 85] [Article Influence: 8.1] [Reference Citation Analysis]
211 Yang D, Tewary P, de la Rosa G, Wei F, Oppenheim JJ. The alarmin functions of high-mobility group proteins. Biochim Biophys Acta 2010;1799:157-63. [PMID: 20123077 DOI: 10.1016/j.bbagrm.2009.11.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
212 Di Maggio S, Milano G, De Marchis F, D'Ambrosio A, Bertolotti M, Palacios BS, Badi I, Sommariva E, Pompilio G, Capogrossi MC, Raucci A. Non-oxidizable HMGB1 induces cardiac fibroblasts migration via CXCR4 in a CXCL12-independent manner and worsens tissue remodeling after myocardial infarction. Biochim Biophys Acta Mol Basis Dis 2017;1863:2693-704. [PMID: 28716707 DOI: 10.1016/j.bbadis.2017.07.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
213 Tang D, Kang R, Xiao W, Jiang L, Liu M, Shi Y, Wang K, Wang H, Xiao X. Nuclear heat shock protein 72 as a negative regulator of oxidative stress (hydrogen peroxide)-induced HMGB1 cytoplasmic translocation and release. J Immunol 2007;178:7376-84. [PMID: 17513788 DOI: 10.4049/jimmunol.178.11.7376] [Cited by in Crossref: 69] [Cited by in F6Publishing: 67] [Article Influence: 4.6] [Reference Citation Analysis]
214 Tang D, Kang R, Zeh HJ, Lotze MT. High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal. 2011;14:1315-1335. [PMID: 20969478 DOI: 10.1089/ars.2010.3356] [Cited by in Crossref: 322] [Cited by in F6Publishing: 304] [Article Influence: 29.3] [Reference Citation Analysis]
215 Richard SA. Exploring the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Glycyrrhizic and Glycyrrhetinic Acids. Mediators Inflamm 2021;2021:6699560. [PMID: 33505216 DOI: 10.1155/2021/6699560] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
216 Du D, Yan J, Ren J, Lv H, Li Y, Xu S, Wang Y, Ma S, Qu J, Tang W, Hu Z, Yu S. Synthesis, biological evaluation, and molecular modeling of glycyrrhizin derivatives as potent high-mobility group box-1 inhibitors with anti-heart-failure activity in vivo. J Med Chem 2013;56:97-108. [PMID: 23199028 DOI: 10.1021/jm301248y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
217 Liu G, Wu Y, Gong S, Zhao Y. Toll-like receptors and graft rejection. Transpl Immunol 2006;16:25-31. [PMID: 16701173 DOI: 10.1016/j.trim.2006.03.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
218 Mosca MJ, Carr AJ, Snelling SJB, Wheway K, Watkins B, Dakin SG. Differential expression of alarmins-S100A9, IL-33, HMGB1 and HIF-1α in supraspinatus tendinopathy before and after treatment. BMJ Open Sport Exerc Med 2017;3:e000225. [PMID: 28761710 DOI: 10.1136/bmjsem-2017-000225] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
219 Gangemi S, Casciaro M, Trapani G, Quartuccio S, Navarra M, Pioggia G, Imbalzano E. Association between HMGB1 and COPD: A Systematic Review. Mediators Inflamm 2015;2015:164913. [PMID: 26798204 DOI: 10.1155/2015/164913] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
220 Bollini S, Smart N, Riley PR. Resident cardiac progenitor cells: at the heart of regeneration. J Mol Cell Cardiol 2011;50:296-303. [PMID: 20643135 DOI: 10.1016/j.yjmcc.2010.07.006] [Cited by in Crossref: 113] [Cited by in F6Publishing: 96] [Article Influence: 9.4] [Reference Citation Analysis]
221 Lin L, Park S, Lakatta EG. RAGE signaling in inflammation and arterial aging. Front Biosci (Landmark Ed) 2009;14:1403-13. [PMID: 19273137 DOI: 10.2741/3315] [Cited by in Crossref: 106] [Cited by in F6Publishing: 103] [Article Influence: 8.2] [Reference Citation Analysis]
222 Krieg AM. TLR9 and DNA 'feel' RAGE. Nat Immunol 2007;8:475-7. [PMID: 17440455 DOI: 10.1038/ni0507-475] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
223 Cheng B, Jia C, Liu C, Lu X, Zhong N, Zhang Z, Fan W, Li Y. Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma. Digestive and Liver Disease 2008;40:446-52. [DOI: 10.1016/j.dld.2007.11.024] [Cited by in Crossref: 68] [Cited by in F6Publishing: 75] [Article Influence: 4.9] [Reference Citation Analysis]
224 Salpietro C, Cuppari C, Grasso L, Tosca MA, Miraglia Del Giudice M, La Rosa M, Marseglia GL, Salpietro A, Ciprandi G. Nasal high-mobility group box-1 protein in children with allergic rhinitis. Int Arch Allergy Immunol 2013;161:116-21. [PMID: 23343652 DOI: 10.1159/000345246] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
225 Zha C, Meng X, Li L, Mi S, Qian D, Li Z, Wu P, Hu S, Zhao S, Cai J, Liu Y. Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumour microenvironment via the HMGB1/RAGE/IL-8 axis.Cancer Biol Med. 2020;17:154-168. [PMID: 32296583 DOI: 10.20892/j.issn.2095-3941.2019.0353] [Cited by in Crossref: 8] [Cited by in F6Publishing: 28] [Reference Citation Analysis]
226 Zampell JC, Yan A, Avraham T, Andrade V, Malliaris S, Aschen S, Rockson SG, Mehrara BJ. Temporal and spatial patterns of endogenous danger signal expression after wound healing and in response to lymphedema. Am J Physiol Cell Physiol 2011;300:C1107-21. [PMID: 21248077 DOI: 10.1152/ajpcell.00378.2010] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
227 Vénéreau E, Ceriotti C, Bianchi ME. DAMPs from Cell Death to New Life. Front Immunol 2015;6:422. [PMID: 26347745 DOI: 10.3389/fimmu.2015.00422] [Cited by in Crossref: 312] [Cited by in F6Publishing: 295] [Article Influence: 44.6] [Reference Citation Analysis]
228 Jube S, Rivera ZS, Bianchi ME, Powers A, Wang E, Pagano I, Pass HI, Gaudino G, Carbone M, Yang H. Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma. Cancer Res 2012;72:3290-301. [PMID: 22552293 DOI: 10.1158/0008-5472.CAN-11-3481] [Cited by in Crossref: 155] [Cited by in F6Publishing: 104] [Article Influence: 15.5] [Reference Citation Analysis]
229 Suda K, Takeuchi H, Ishizaka A, Kitagawa Y. High-mobility-group box chromosomal protein 1 as a new target for modulating stress response. Surg Today 2010;40:592-601. [DOI: 10.1007/s00595-009-4232-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
230 Wild CA, Bergmann C, Fritz G, Schuler P, Hoffmann TK, Lotfi R, Westendorf A, Brandau S, Lang S. HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells. International Immunology 2012;24:485-94. [DOI: 10.1093/intimm/dxs051] [Cited by in Crossref: 53] [Cited by in F6Publishing: 61] [Article Influence: 5.3] [Reference Citation Analysis]
231 Wild CA, Brandau S, Lotfi R, Mattheis S, Gu X, Lang S, Bergmann C. HMGB1 is overexpressed in tumor cells and promotes activity of regulatory T cells in patients with head and neck cancer. Oral Oncol 2012;48:409-16. [PMID: 22265157 DOI: 10.1016/j.oraloncology.2011.12.009] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
232 Völp K, Brezniceanu ML, Bösser S, Brabletz T, Kirchner T, Göttel D, Joos S, Zörnig M. Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas. Gut 2006;55:234-42. [PMID: 16118352 DOI: 10.1136/gut.2004.062729] [Cited by in Crossref: 92] [Cited by in F6Publishing: 96] [Article Influence: 5.4] [Reference Citation Analysis]
233 Meregalli M, Farini A, Parolini D, Maciotta S, Torrente Y. Stem cell therapies to treat muscular dystrophy: progress to date. BioDrugs 2010;24:237-47. [PMID: 20623990 DOI: 10.2165/11534300-000000000-00000] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
234 Raucci A, Palumbo R, Bianchi ME. HMGB1: a signal of necrosis. Autoimmunity. 2007;40:285-289. [PMID: 17516211 DOI: 10.1080/08916930701356978] [Cited by in Crossref: 124] [Cited by in F6Publishing: 118] [Article Influence: 8.3] [Reference Citation Analysis]
235 Troia R, Giunti M, Calipa S, Goggs R. Cell-Free DNA, High-Mobility Group Box-1, and Procalcitonin Concentrations in Dogs With Gastric Dilatation-Volvulus Syndrome. Front Vet Sci 2018;5:67. [PMID: 29686994 DOI: 10.3389/fvets.2018.00067] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
236 Porto A, Palumbo R, Pieroni M, Aprigliano G, Chiesa R, Sanvito F, Maseri A, Bianchi ME. Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein. FASEB J 2006;20:2565-6. [PMID: 17060403 DOI: 10.1096/fj.06-5867fje] [Cited by in Crossref: 116] [Cited by in F6Publishing: 115] [Article Influence: 7.3] [Reference Citation Analysis]
237 Mitola S, Belleri M, Urbinati C, Coltrini D, Sparatore B, Pedrazzi M, Melloni E, Presta M. Cutting Edge: Extracellular High Mobility Group Box-1 Protein Is a Proangiogenic Cytokine. J Immunol 2005;176:12-5. [DOI: 10.4049/jimmunol.176.1.12] [Cited by in Crossref: 156] [Cited by in F6Publishing: 156] [Article Influence: 9.2] [Reference Citation Analysis]
238 Oppenheim JJ, Yang D. Alarmins: chemotactic activators of immune responses. Curr Opin Immunol. 2005;17:359-365. [PMID: 15955682 DOI: 10.1016/j.coi.2005.06.002] [Cited by in Crossref: 523] [Cited by in F6Publishing: 516] [Article Influence: 30.8] [Reference Citation Analysis]
239 Dumitriu IE, Bianchi ME, Bacci M, Manfredi AA, Rovere-querini P. The secretion of HMGB1 is required for the migration of maturing dendritic cells. Journal of Leukocyte Biology 2007;81:84-91. [DOI: 10.1189/jlb.0306171] [Cited by in Crossref: 164] [Cited by in F6Publishing: 160] [Article Influence: 10.3] [Reference Citation Analysis]
240 Rabadi MM, Kuo MC, Ghaly T, Rabadi SM, Weber M, Goligorsky MS, Ratliff BB. Interaction between uric acid and HMGB1 translocation and release from endothelial cells. Am J Physiol Renal Physiol. 2012;302:F730-F741. [PMID: 22189943 DOI: 10.1152/ajprenal.00520.2011] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 3.9] [Reference Citation Analysis]
241 Fu S, Wu D, Jiang W, Li J, Long J, Jia C, Zhou T. Molecular Biomarkers in Drug-Induced Liver Injury: Challenges and Future Perspectives. Front Pharmacol 2019;10:1667. [PMID: 32082163 DOI: 10.3389/fphar.2019.01667] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
242 Srikrishna G, Freeze HH. Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia 2009;11:615-28. [PMID: 19568407 DOI: 10.1593/neo.09284] [Cited by in Crossref: 178] [Cited by in F6Publishing: 176] [Article Influence: 13.7] [Reference Citation Analysis]
243 Liu Y, Chen GY, Zheng P. Sialoside-based pattern recognitions discriminating infections from tissue injuries. Curr Opin Immunol 2011;23:41-5. [PMID: 21208791 DOI: 10.1016/j.coi.2010.10.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
244 Ghulam Muhammad AK, Candolfi M, King GD, Yagiz K, Foulad D, Mineharu Y, Kroeger KM, Treuer KA, Nichols WS, Sanderson NS, Yang J, Khayznikov M, Van Rooijen N, Lowenstein PR, Castro MG. Antiglioma immunological memory in response to conditional cytotoxic/immune-stimulatory gene therapy: humoral and cellular immunity lead to tumor regression. Clin Cancer Res 2009;15:6113-27. [PMID: 19789315 DOI: 10.1158/1078-0432.CCR-09-1087] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
245 Lin Q, Yang XP, Fang D, Ren X, Zhou H, Fang J, Liu X, Zhou S, Wen F, Yao X, Wang JM, Su SB. High-mobility group box-1 mediates toll-like receptor 4-dependent angiogenesis. Arterioscler Thromb Vasc Biol 2011;31:1024-32. [PMID: 21372296 DOI: 10.1161/ATVBAHA.111.224048] [Cited by in Crossref: 69] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
246 Candolfi M, Kroeger KM, Muhammad AK, Yagiz K, Farrokhi C, Pechnick RN, Lowenstein PR, Castro MG. Gene therapy for brain cancer: combination therapies provide enhanced efficacy and safety. Curr Gene Ther 2009;9:409-21. [PMID: 19860655 DOI: 10.2174/156652309789753301] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
247 Aikawa E, Fujita R, Kikuchi Y, Kaneda Y, Tamai K. Systemic high-mobility group box 1 administration suppresses skin inflammation by inducing an accumulation of PDGFRα(+) mesenchymal cells from bone marrow. Sci Rep 2015;5:11008. [PMID: 26046579 DOI: 10.1038/srep11008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
248 Oda Y, Tsuruta R, Fujita M, Kaneda K, Kawamura Y, Izumi T, Kasaoka S, Maruyama I, Maekawa T. Prediction of the neurological outcome with intrathecal high mobility group box 1 and S100B in cardiac arrest victims: A pilot study. Resuscitation 2012;83:1006-12. [DOI: 10.1016/j.resuscitation.2012.01.030] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
249 Rouhiainen A, Kuja-Panula J, Tumova S, Rauvala H. RAGE-mediated cell signaling. Methods Mol Biol. 2013;963:239-263. [PMID: 23296615 DOI: 10.1007/978-1-62703-230-8_15] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 5.6] [Reference Citation Analysis]
250 Klune JR, Dhupar R, Cardinal J, Billiar TR, Tsung A. HMGB1: endogenous danger signaling. Mol Med. 2008;14:476-484. [PMID: 18431461 DOI: 10.2119/2008-00034.klune] [Cited by in Crossref: 509] [Cited by in F6Publishing: 304] [Article Influence: 36.4] [Reference Citation Analysis]
251 Chen MQ, Luan JJ. HMGB1 promotes bone fracture healing through activation of ERK signaling pathway in a rat tibial fracture model. Kaohsiung J Med Sci 2019;35:550-8. [PMID: 31162822 DOI: 10.1002/kjm2.12095] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
252 Xin-peng Z, Yong-hua H, Yong L, Jing-jing W, Guang-hua W, Ren-jie W, Min Z. A high-mobility group box 1 that binds to DNA, enhances pro-inflammatory activity, and acts as an anti-infection molecule in black rockfish, Sebastes schlegelii. Fish & Shellfish Immunology 2016;56:402-9. [DOI: 10.1016/j.fsi.2016.07.034] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
253 Yin H, Yang X, Gu W, Liu Y, Li X, Huang X, Zhu X, Tao Y, Gou X, He W. HMGB1-mediated autophagy attenuates gemcitabine-induced apoptosis in bladder cancer cells involving JNK and ERK activation. Oncotarget 2017;8:71642-56. [PMID: 29069735 DOI: 10.18632/oncotarget.17796] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
254 Hiramoto K, Yamate Y, Goto K, Ohnishi S, Morita A, Yoshikawa N, Kawanishi S. Glycyrrhizin ameliorates melanoma cell extravasation into mouse lungs by regulating signal transduction through HMGB1 and its receptors. J Clin Biochem Nutr 2021;69:52-60. [PMID: 34376914 DOI: 10.3164/jcbn.20-125] [Reference Citation Analysis]
255 Iverson D, Serrano C, Brahan AM, Shams A, Totsingan F, Bell AJ Jr. Characterization of the structural and protein recognition properties of hybrid PNA-DNA four-way junctions. Arch Biochem Biophys 2015;587:1-11. [PMID: 26348651 DOI: 10.1016/j.abb.2015.08.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
256 Meng E, Guo Z, Wang H, Jin J, Wang J, Wang H, Wu C, Wang L. High mobility group box 1 protein inhibits the proliferation of human mesenchymal stem cells and promotes their migration and differentiation along osteoblastic pathway. Stem Cells Dev 2008;17:805-13. [PMID: 18715162 DOI: 10.1089/scd.2007.0276] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 4.5] [Reference Citation Analysis]
257 Burns G, Ortega-martinez O, Thorndyke MC, Peck LS, Dupont S, Clark MS. Dynamic gene expression profiles during arm regeneration in the brittle star Amphiura filiformis. Journal of Experimental Marine Biology and Ecology 2011;407:315-22. [DOI: 10.1016/j.jembe.2011.06.032] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
258 Carfì-pavia F, Turturici G, Geraci F, Brucato V, La Carrubba V, Luparello C, Sconzo G. Porous poly (L-lactic acid) scaffolds are optimal substrates for internal colonization by A6 mesoangioblasts and immunocytochemical analyses. J Biosci 2009;34:873-9. [DOI: 10.1007/s12038-009-0101-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
259 Hernández ÁP, Juanes-Velasco P, Landeira-Viñuela A, Bareke H, Montalvillo E, Góngora R, Fuentes M. Restoring the Immunity in the Tumor Microenvironment: Insights into Immunogenic Cell Death in Onco-Therapies. Cancers (Basel) 2021;13:2821. [PMID: 34198850 DOI: 10.3390/cancers13112821] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
260 Yao X, Zhao G, Yang H, Hong X, Bie L, Liu G. Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma. J Cancer Res Clin Oncol. 2010;136:677-684. [PMID: 19898867 DOI: 10.1007/s00432-009-0706-1] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 4.7] [Reference Citation Analysis]
261 Palmblad K, Sundberg E, Diez M, Söderling R, Aveberger AC, Andersson U, Harris HE. Morphological characterization of intra-articular HMGB1 expression during the course of collagen-induced arthritis. Arthritis Res Ther 2007;9:R35. [PMID: 17397533 DOI: 10.1186/ar2155] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
262 Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol. 2005;5:331-342. [PMID: 15803152 DOI: 10.1038/nri1594] [Cited by in Crossref: 1635] [Cited by in F6Publishing: 1605] [Article Influence: 96.2] [Reference Citation Analysis]
263 Davis HM, Valdez S, Gomez L, Malicky P, White FA, Subler MA, Windle JJ, Bidwell JP, Bruzzaniti A, Plotkin LI. High mobility group box 1 protein regulates osteoclastogenesis through direct actions on osteocytes and osteoclasts in vitro. J Cell Biochem 2019;120:16741-9. [PMID: 31106449 DOI: 10.1002/jcb.28932] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
264 Raucci A, Cugusi S, Antonelli A, Barabino SM, Monti L, Bierhaus A, Reiss K, Saftig P, Bianchi ME. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J 2008;22:3716-27. [PMID: 18603587 DOI: 10.1096/fj.08-109033] [Cited by in Crossref: 364] [Cited by in F6Publishing: 362] [Article Influence: 26.0] [Reference Citation Analysis]
265 Quattrocelli M, Cassano M, Crippa S, Perini I, Sampaolesi M. Cell therapy strategies and improvements for muscular dystrophy. Cell Death Differ 2010;17:1222-9. [DOI: 10.1038/cdd.2009.160] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
266 Abe H, Okazawa M, Oyama T, Yamazaki H, Yoshimori A, Kamiya T, Tsukimoto M, Takao K, Sugita Y, Sakagami H, Abe T, Tanuma SI. A Unique Anti-Cancer 3-Styrylchromone Suppresses Inflammatory Response via HMGB1-RAGE Signaling. Medicines (Basel) 2021;8:17. [PMID: 33805209 DOI: 10.3390/medicines8040017] [Reference Citation Analysis]
267 Tang D, Kang R, Zeh HJ, Lotze MT. High-mobility group box 1 and cancer. Biochim Biophys Acta. 2010;1799:131-140. [PMID: 20123075 DOI: 10.1016/j.bbagrm.2009.11.014] [Cited by in Crossref: 334] [Cited by in F6Publishing: 345] [Article Influence: 27.8] [Reference Citation Analysis]
268 Kitahara T, Takeishi Y, Harada M, Niizeki T, Suzuki S, Sasaki T, Ishino M, Bilim O, Nakajima O, Kubota I. High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice. Cardiovasc Res 2008;80:40-6. [PMID: 18558628 DOI: 10.1093/cvr/cvn163] [Cited by in Crossref: 104] [Cited by in F6Publishing: 97] [Article Influence: 7.4] [Reference Citation Analysis]
269 Li L, Ling Y, Huang M, Yin T, Gou SM, Zhan NY, Xiong JX, Wu HS, Yang ZY, Wang CY. Heparin inhibits the inflammatory response induced by LPS and HMGB1 by blocking the binding of HMGB1 to the surface of macrophages. Cytokine 2015;72:36-42. [PMID: 25562836 DOI: 10.1016/j.cyto.2014.12.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
270 Moritake H, Obara M, Sameshima N, Asada Y, Komatsu H, Hyakuna N, Sugita K, Ishida Y, Kato M, Tanizawa A, Deguchi T, Imamura T, Kitanaka A, Shimoda K, Kamimura S, Nunoi H. Analysis of the molecular mechanism underlying bone marrow necrosis with acute lymphoblastic leukemia. Int J Hematol 2015;102:349-56. [PMID: 26185062 DOI: 10.1007/s12185-015-1843-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
271 Dong Xda E, Ito N, Lotze MT, Demarco RA, Popovic P, Shand SH, Watkins S, Winikoff S, Brown CK, Bartlett DL, Zeh HJ 3rd. High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy. J Immunother 2007;30:596-606. [PMID: 17667523 DOI: 10.1097/CJI.0b013e31804efc76] [Cited by in Crossref: 78] [Cited by in F6Publishing: 59] [Article Influence: 5.2] [Reference Citation Analysis]
272 Sachdev U, Cui X, Xu J, Xu J, Tzeng E. MyD88 and TRIF mediate divergent inflammatory and regenerative responses to skeletal muscle ischemia. Physiol Rep 2014;2:e12006. [PMID: 24844636 DOI: 10.14814/phy2.12006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
273 Zhang H, Ding L, Shen T, Peng D. HMGB1 involved in stress-induced depression and its neuroinflammatory priming role: a systematic review. Gen Psychiatr. 2019;32:e100084. [PMID: 31552388 DOI: 10.1136/gpsych-2019-100084] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
274 Polyanichko AM, Rodionova TJ, Vorob’ev VI, Chikhirzhina EV. Conformational properties of nuclear protein HMGB1 and specificity of its interaction with DNA. Cell Tiss Biol 2011;5:114-9. [DOI: 10.1134/s1990519x1102012x] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
275 Biscetti F, Straface G, De Cristofaro R, Lancellotti S, Rizzo P, Arena V, Stigliano E, Pecorini G, Egashira K, De Angelis G, Ghirlanda G, Flex A. High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism. Diabetes 2010;59:1496-505. [PMID: 20200317 DOI: 10.2337/db09-1507] [Cited by in Crossref: 77] [Cited by in F6Publishing: 75] [Article Influence: 6.4] [Reference Citation Analysis]
276 Cappelletti C, Galbardi B, Bruttini M, Salerno F, Canioni E, Pasanisi MB, Rodolico C, Brizzi T, Mora M, Renieri A, Maggi L, Bernasconi P, Mantegazza R. Aging-associated genes and let-7 microRNAs: a contribution to myogenic program dysregulation in oculopharyngeal muscular dystrophy. FASEB J 2019;33:7155-67. [PMID: 30860873 DOI: 10.1096/fj.201801577RR] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
277 Biressi S, Filareto A, Rando TA. Stem cell therapy for muscular dystrophies. J Clin Invest 2020;130:5652-64. [PMID: 32946430 DOI: 10.1172/JCI142031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
278 Wenzhao L, Jiangdong N, Deye S, Muliang D, Junjie W, Xianzhe H, Mingming Y, Jun H. Dual regulatory roles of HMGB1 in inflammatory reaction of chondrocyte cells and mice. Cell Cycle 2019;18:2268-80. [PMID: 31313630 DOI: 10.1080/15384101.2019.1642680] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
279 Pisetsky DS, Erlandsson-Harris H, Andersson U. High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease. Arthritis Res Ther. 2008;10:209. [PMID: 18598385 DOI: 10.1186/ar2440] [Cited by in Crossref: 134] [Cited by in F6Publishing: 132] [Article Influence: 9.6] [Reference Citation Analysis]
280 Tirone M, Tran NL, Ceriotti C, Gorzanelli A, Canepari M, Bottinelli R, Raucci A, Di Maggio S, Santiago C, Mellado M, Saclier M, François S, Careccia G, He M, De Marchis F, Conti V, Ben Larbi S, Cuvellier S, Casalgrandi M, Preti A, Chazaud B, Al-Abed Y, Messina G, Sitia G, Brunelli S, Bianchi ME, Vénéreau E. High mobility group box 1 orchestrates tissue regeneration via CXCR4. J Exp Med 2018;215:303-18. [PMID: 29203538 DOI: 10.1084/jem.20160217] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 13.8] [Reference Citation Analysis]
281 Yang J, Liu X, Zhou Y, Wang G, Gao C, Su Q. Hyperbaric Oxygen Alleviates Experimental (Spinal Cord) Injury by Downregulating HMGB1/NF-κB Expression: . Spine 2013;38:E1641-8. [DOI: 10.1097/brs.0000000000000005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
282 Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, Parroche P, Drabic S, Golenbock D, Sirois C, Hua J, An LL, Audoly L, La Rosa G, Bierhaus A, Naworth P, Marshak-Rothstein A, Crow MK, Fitzgerald KA, Latz E, Kiener PA, Coyle AJ. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007;8:487-96. [PMID: 17417641 DOI: 10.1038/ni1457] [Cited by in Crossref: 926] [Cited by in F6Publishing: 929] [Article Influence: 61.7] [Reference Citation Analysis]
283 Huan CC, Wang HX, Sheng XX, Wang R, Wang X, Liao Y, Liu QF, Tong GZ, Ding C, Fan HJ, Wu JQ, Mao X. Porcine epidemic diarrhea virus nucleoprotein contributes to HMGB1 transcription and release by interacting with C/EBP-β. Oncotarget 2016;7:75064-80. [PMID: 27634894 DOI: 10.18632/oncotarget.11991] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
284 Camps J, Grosemans H, Gijsbers R, Maes C, Sampaolesi M. Growth Factor Screening in Dystrophic Muscles Reveals PDGFB/PDGFRB-Mediated Migration of Interstitial Stem Cells. Int J Mol Sci 2019;20:E1118. [PMID: 30841538 DOI: 10.3390/ijms20051118] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
285 Yan SF, Ramasamy R, Schmidt AM. The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature. Circ Res. 2010;106:842-853. [PMID: 20299674 DOI: 10.1161/circresaha.109.212217] [Cited by in Crossref: 243] [Cited by in F6Publishing: 148] [Article Influence: 20.3] [Reference Citation Analysis]
286 O'callaghan A, Wang J, Redmond HP. HMGB1 as a key mediator of tissue response to injury: roles in inflammation and tissue repair. Eur Surg 2006;38:283-92. [DOI: 10.1007/s10353-006-0255-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
287 Zhang Y, Hen FT, Li RF, Lian JQ, Yang ZH, Gao HG. Cloning and expression of HMGB1 A box and B box cDNAs. Shijie Huaren Xiaohua Zazhi 2004; 12(6): 1365-1368 [DOI: 10.11569/wcjd.v12.i6.1365] [Reference Citation Analysis]
288 Galvez BG, Sampaolesi M, Brunelli S, Covarello D, Gavina M, Rossi B, Constantin G, Torrente Y, Cossu G. Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability. J Cell Biol 2006;174:231-43. [PMID: 16831885 DOI: 10.1083/jcb.200512085] [Cited by in Crossref: 155] [Cited by in F6Publishing: 139] [Article Influence: 9.7] [Reference Citation Analysis]
289 Bernal A, San Martín N, Fernández M, Covarello D, Molla F, Soldo A, Latini R, Cossu G, Gálvez BG. L-selectin and SDF-1 enhance the migration of mouse and human cardiac mesoangioblasts. Cell Death Differ 2012;19:345-55. [PMID: 21869829 DOI: 10.1038/cdd.2011.110] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
290 Donndorf P, Useini D, Lux CA, Vollmar B, Delyagina E, Laupheimer M, Kaminski A, Steinhoff G. Analyzing migratory properties of human CD133(+) stem cells in vivo after intraoperative sternal bone marrow isolation. Cell Transplant. 2013;22:1627-1635. [PMID: 23051098 DOI: 10.3727/096368912x657729] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
291 Vakkila J, Lotze MT. Inflammation and necrosis promote tumour growth. Nat Rev Immunol. 2004;4:641-648. [PMID: 15286730 DOI: 10.1038/nri1415] [Cited by in Crossref: 424] [Cited by in F6Publishing: 398] [Article Influence: 23.6] [Reference Citation Analysis]
292 de Carvalho GC, Hirata FYA, Domingues R, Figueiredo CA, Zaniboni MC, Pereira NV, Sotto MN, Aoki V, da Silva Duarte AJ, Sato MN. Up-regulation of HMGB1 and TLR4 in skin lesions of lichen planus. Arch Dermatol Res 2018;310:523-8. [PMID: 29728859 DOI: 10.1007/s00403-018-1837-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
293 Chuangui C, Peng T, Zhentao Y. The expression of high mobility group box 1 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma. Pathol Oncol Res. 2012;18:1021-1027. [PMID: 22544356 DOI: 10.1007/s12253-012-9539-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
294 Liu L, Deng J, Ji Q, Peng B. High-mobility Group Box 1 Is Associated with the Inflammatory Infiltration and Alveolar Bone Destruction in Rats Experimental Periapical Lesions. J Endod 2017;43:964-9. [PMID: 28389071 DOI: 10.1016/j.joen.2016.11.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
295 Mouratidis PXE, Ter Haar G. HSP90 inhibition acts synergistically with heat to induce a pro-immunogenic form of cell death in colon cancer cells. Int J Hyperthermia 2021;38:1443-56. [PMID: 34612127 DOI: 10.1080/02656736.2021.1983036] [Reference Citation Analysis]
296 Castiglioni A, Canti V, Rovere-Querini P, Manfredi AA. High-mobility group box 1 (HMGB1) as a master regulator of innate immunity. Cell Tissue Res 2011;343:189-99. [PMID: 20835834 DOI: 10.1007/s00441-010-1033-1] [Cited by in Crossref: 74] [Cited by in F6Publishing: 78] [Article Influence: 6.2] [Reference Citation Analysis]
297 Lee W, Ku SK, Bae JW, Bae JS. Inhibitory effects of lycopene on HMGB1-mediated pro-inflammatory responses in both cellular and animal models. Food Chem Toxicol 2012;50:1826-33. [PMID: 22429818 DOI: 10.1016/j.fct.2012.03.003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
298 Zhang W, Lavine KJ, Epelman S, Evans SA, Weinheimer CJ, Barger PM, Mann DL. Necrotic myocardial cells release damage-associated molecular patterns that provoke fibroblast activation in vitro and trigger myocardial inflammation and fibrosis in vivo. J Am Heart Assoc 2015;4:e001993. [PMID: 26037082 DOI: 10.1161/JAHA.115.001993] [Cited by in Crossref: 83] [Cited by in F6Publishing: 58] [Article Influence: 11.9] [Reference Citation Analysis]
299 Romero R, Chaiworapongsa T, Alpay Savasan Z, Xu Y, Hussein Y, Dong Z, Kusanovic JP, Kim CJ, Hassan SS. Damage-associated molecular patterns (DAMPs) in preterm labor with intact membranes and preterm PROM: a study of the alarmin HMGB1. J Matern Fetal Neonatal Med 2011;24:1444-55. [PMID: 21958433 DOI: 10.3109/14767058.2011.591460] [Cited by in Crossref: 139] [Cited by in F6Publishing: 148] [Article Influence: 12.6] [Reference Citation Analysis]
300 Palumbo R, Bianchi ME. High mobility group box 1 protein, a cue for stem cell recruitment. Biochemical Pharmacology 2004;68:1165-70. [DOI: 10.1016/j.bcp.2004.03.048] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 3.7] [Reference Citation Analysis]
301 Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer. 2012;12:860-875. [PMID: 23151605 DOI: 10.1038/nrc3380] [Cited by in Crossref: 902] [Cited by in F6Publishing: 884] [Article Influence: 90.2] [Reference Citation Analysis]
302 Biscetti F, Gentileschi S, Bertucci F, Servillo M, Arena V, Angelini F, Stigliano E, Bonanno G, Scambia G, Sacchetti B, Pierelli L, Landolfi R, Flex A. The angiogenic properties of human adipose-derived stem cells (HASCs) are modulated by the High mobility group box protein 1 (HMGB1). Int J Cardiol 2017;249:349-56. [PMID: 28967436 DOI: 10.1016/j.ijcard.2017.09.165] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
303 Anuranjani, Bala M. Concerted action of Nrf2-ARE pathway, MRN complex, HMGB1 and inflammatory cytokines - implication in modification of radiation damage. Redox Biol 2014;2:832-46. [PMID: 25009785 DOI: 10.1016/j.redox.2014.02.008] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 7.9] [Reference Citation Analysis]
304 Sparatore B, Patrone M, Passalacqua M, Pedrazzi M, Ledda S, Pontremoli S, Melloni E. Activation of A431 human carcinoma cell motility by extracellular high-mobility group box 1 protein and epidermal growth factor stimuli. Biochem J 2005;389:215-21. [PMID: 15733057 DOI: 10.1042/BJ20050053] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
305 Limana F, Germani A, Zacheo A, Kajstura J, Di Carlo A, Borsellino G, Leoni O, Palumbo R, Battistini L, Rastaldo R, Müller S, Pompilio G, Anversa P, Bianchi ME, Capogrossi MC. Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ Res 2005;97:e73-83. [PMID: 16166556 DOI: 10.1161/01.RES.0000186276.06104.04] [Cited by in Crossref: 223] [Cited by in F6Publishing: 109] [Article Influence: 13.1] [Reference Citation Analysis]
306 Parrish WR, Gallowitsch-Puerta M, Czura CJ, Tracey KJ. Experimental therapeutic strategies for severe sepsis: mediators and mechanisms. Ann N Y Acad Sci 2008;1144:210-36. [PMID: 19076379 DOI: 10.1196/annals.1418.011] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 3.8] [Reference Citation Analysis]
307 Chung HW, Lee SG, Kim H, Hong DJ, Chung JB, Stroncek D, Lim JB. Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer. J Transl Med 2009;7:38. [PMID: 19476625 DOI: 10.1186/1479-5876-7-38] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 5.6] [Reference Citation Analysis]
308 Musumeci D, Roviello GN, Montesarchio D. An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. Pharmacol Ther. 2014;141:347-357. [PMID: 24220159 DOI: 10.1016/j.pharmthera.2013.11.001] [Cited by in Crossref: 193] [Cited by in F6Publishing: 195] [Article Influence: 21.4] [Reference Citation Analysis]
309 Ito T. PAMPs and DAMPs as triggers for DIC. J Intensive Care 2014;2:67. [PMID: 25705424 DOI: 10.1186/s40560-014-0065-0] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 8.5] [Reference Citation Analysis]
310 Osoegawa A, Yano T, Yamanaka T, Tagawa T, Shoji F, Yoshino I, Taketomi A, Ito H, Kakeji Y, Maehara Y. Plasma high-mobility group box 1 as an indicator of surgical stress. Surg Today 2011;41:903-7. [DOI: 10.1007/s00595-010-4371-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
311 Cormier SA, Taranova AG, Bedient C, Nguyen T, Protheroe C, Pero R, Dimina D, Ochkur SI, O'Neill K, Colbert D, Lombari TR, Constant S, McGarry MP, Lee JJ, Lee NA. Pivotal advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J Leukoc Biol. 2006;79:1131-1139. [PMID: 16617160 DOI: 10.1189/jlb.0106027] [Cited by in Crossref: 119] [Cited by in F6Publishing: 115] [Article Influence: 7.4] [Reference Citation Analysis]
312 Sciorati C, Galvez BG, Brunelli S, Tagliafico E, Ferrari S, Cossu G, Clementi E. Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy. J Cell Sci 2006;119:5114-23. [PMID: 17158915 DOI: 10.1242/jcs.03300] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
313 Rovere-Querini P, Manfredi AA, Sabbadini MG. Environmental adjuvants, apoptosis and the censorship over autoimmunity. Autoimmun Rev 2005;4:555-60. [PMID: 16214095 DOI: 10.1016/j.autrev.2005.04.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
314 Nojiri S, Tsuchiya A, Natsui K, Takeuchi S, Watanabe T, Kojima Y, Watanabe Y, Kamimura H, Ogawa M, Motegi S, Iwasawa T, Sato T, Kumagai M, Ishii Y, Kitayama T, Li YT, Ouchi Y, Shimbo T, Takamura M, Tamai K, Terai S. Synthesized HMGB1 peptide attenuates liver inflammation and suppresses fibrosis in mice. Inflamm Regen 2021;41:28. [PMID: 34565478 DOI: 10.1186/s41232-021-00177-4] [Reference Citation Analysis]
315 Luan ZG, Zhang H, Yang PT, Ma XC, Zhang C, Guo RX. HMGB1 activates nuclear factor-κB signaling by RAGE and increases the production of TNF-α in human umbilical vein endothelial cells. Immunobiology 2010;215:956-62. [PMID: 20163887 DOI: 10.1016/j.imbio.2009.11.001] [Cited by in Crossref: 90] [Cited by in F6Publishing: 88] [Article Influence: 7.5] [Reference Citation Analysis]
316 Matena J, Petersen S, Gieseke M, Kampmann A, Teske M, Beyerbach M, Murua Escobar H, Haferkamp H, Gellrich NC, Nolte I. SLM produced porous titanium implant improvements for enhanced vascularization and osteoblast seeding. Int J Mol Sci 2015;16:7478-92. [PMID: 25849656 DOI: 10.3390/ijms16047478] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 6.7] [Reference Citation Analysis]
317 Bianchi ME. HMGB1 loves company. J Leukoc Biol. 2009;86:573-576. [PMID: 19414536 DOI: 10.1189/jlb.1008585] [Cited by in Crossref: 280] [Cited by in F6Publishing: 281] [Article Influence: 21.5] [Reference Citation Analysis]
318 Kuroiwa Y, Takakusagi Y, Kusayanagi T, Kuramochi K, Imai T, Hirayama T, Ito I, Yoshida M, Sakaguchi K, Sugawara F. Identification and characterization of the direct interaction between methotrexate (MTX) and high-mobility group box 1 (HMGB1) protein. PLoS One 2013;8:e63073. [PMID: 23658798 DOI: 10.1371/journal.pone.0063073] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
319 Ghweil AA, Osman HA, Hassan MH, Sabry AM, Mahdy RE, Ahmed AR, Okasha A, Khodeary A, Ameen HH. Validity of serum amyloid A and HMGB1 as biomarkers for early diagnosis of gastric cancer. Cancer Manag Res 2020;12:117-26. [PMID: 32021428 DOI: 10.2147/CMAR.S207934] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
320 Takei H, Baba Y, Hisatsune A, Katsuki H, Miyata T, Yokomizo K, Isohama Y. Glycyrrhizin inhibits interleukin-8 production and nuclear factor-kappaB activity in lung epithelial cells, but not through glucocorticoid receptors. J Pharmacol Sci 2008;106:460-8. [PMID: 18344608 DOI: 10.1254/jphs.fp0072378] [Cited by in Crossref: 40] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
321 Kew RR, Penzo M, Habiel DM, Marcu KB. The IKKα-dependent NF-κB p52/RelB noncanonical pathway is essential to sustain a CXCL12 autocrine loop in cells migrating in response to HMGB1. J Immunol 2012;188:2380-6. [PMID: 22287708 DOI: 10.4049/jimmunol.1102454] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 5.6] [Reference Citation Analysis]
322 Zullo J, Matsumoto K, Xavier S, Ratliff B, Goligorsky MS. The cell secretome, a mediator of cell-to-cell communication. Prostaglandins Other Lipid Mediat 2015;120:17-20. [PMID: 25936481 DOI: 10.1016/j.prostaglandins.2015.03.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
323 Ranzato E, Patrone M, Pedrazzi M, Burlando B. HMGb1 promotes scratch wound closure of HaCaT keratinocytes via ERK1/2 activation. Mol Cell Biochem 2009;332:199-205. [PMID: 19588230 DOI: 10.1007/s11010-009-0192-4] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 3.6] [Reference Citation Analysis]
324 De Mori R, Straino S, Di Carlo A, Mangoni A, Pompilio G, Palumbo R, Bianchi ME, Capogrossi MC, Germani A. Multiple effects of high mobility group box protein 1 in skeletal muscle regeneration. Arterioscler Thromb Vasc Biol 2007;27:2377-83. [PMID: 17872450 DOI: 10.1161/ATVBAHA.107.153429] [Cited by in Crossref: 67] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
325 Morosetti R, Gidaro T, Broccolini A, Gliubizzi C, Sancricca C, Tonali PA, Ricci E, Mirabella M. Mesoangioblasts from facioscapulohumeral muscular dystrophy display in vivo a variable myogenic ability predictable by their in vitro behavior. Cell Transplant 2011;20:1299-313. [PMID: 21176400 DOI: 10.3727/096368910X546571] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
326 Kake S, Kawaguchi H, Nagasato T, Yamada T, Ito T, Maruyama I, Miura N, Tanimoto A. Association Between HMGB1 and Thrombogenesis in a Hyperlipaemia-induced Microminipig Model of Atherosclerosis. In Vivo 2020;34:1871-4. [PMID: 32606157 DOI: 10.21873/invivo.11982] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
327 Giuliani G, Vumbaca S, Fuoco C, Gargioli C, Giorda E, Massacci G, Palma A, Reggio A, Riccio F, Rosina M, Vinci M, Castagnoli L, Cesareni G. SCA-1 micro-heterogeneity in the fate decision of dystrophic fibro/adipogenic progenitors. Cell Death Dis 2021;12:122. [PMID: 33495447 DOI: 10.1038/s41419-021-03408-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
328 Yang D, Oppenheim JJ. Alarmins and antimicrobial immunity. Med Mycol 2009;47 Suppl 1:S146-53. [PMID: 19253139 DOI: 10.1080/13693780902721416] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
329 Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest. 2005;115:572-583. [PMID: 15765139 DOI: 10.1172/jci24283] [Cited by in Crossref: 3] [Cited by in F6Publishing: 168] [Article Influence: 0.2] [Reference Citation Analysis]
330 Riuzzi F, Sorci G, Sagheddu R, Donato R. HMGB1-RAGE regulates muscle satellite cell homeostasis through p38-MAPK- and myogenin-dependent repression of Pax7 transcription. J Cell Sci. 2012;125:1440-1454. [PMID: 22328527 DOI: 10.1242/jcs.092163] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 5.0] [Reference Citation Analysis]
331 Kalinina N, Agrotis A, Antropova Y, DiVitto G, Kanellakis P, Kostolias G, Ilyinskaya O, Tararak E, Bobik A. Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines. Arterioscler Thromb Vasc Biol 2004;24:2320-5. [PMID: 15374849 DOI: 10.1161/01.ATV.0000145573.36113.8a] [Cited by in Crossref: 190] [Cited by in F6Publishing: 77] [Article Influence: 10.6] [Reference Citation Analysis]
332 Berry SE. Concise review: mesoangioblast and mesenchymal stem cell therapy for muscular dystrophy: progress, challenges, and future directions. Stem Cells Transl Med 2015;4:91-8. [PMID: 25391645 DOI: 10.5966/sctm.2014-0060] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
333 Bianchi ME. Significant (re)location: how to use chromatin and/or abundant proteins as messages of life and death. Trends in Cell Biology 2004;14:287-93. [DOI: 10.1016/j.tcb.2004.04.004] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 2.2] [Reference Citation Analysis]